https://www.hikma.com/ 2026-03-18T09:01:28Z https://youtu.be/COoi9lRhrU8 Video Video https://youtu.be/COoi9lRhrU8 https://www.hikma.com/who-we-are/ 2026-03-18T09:13:35Z https://youtu.be/3E5h5NIMmOo?si=jDzIpiGD5UralbCU Video Video https://youtu.be/3E5h5NIMmOo?si=jDzIpiGD5UralbCU https://www.hikma.com/who-we-are/purpose-strategy-and-culture/ 2026-02-10T13:53:34Z https://youtu.be/cno6ML0kBk8 Video Video https://youtu.be/E03Oq6lp9XE Video Video https://youtu.be/3E5h5NIMmOo?si=jDzIpiGD5UralbCU Video Video https://youtu.be/cno6ML0kBk8 https://youtu.be/E03Oq6lp9XE https://youtu.be/3E5h5NIMmOo?si=jDzIpiGD5UralbCU https://www.hikma.com/who-we-are/impact/ 2026-03-18T09:16:41Z https://youtu.be/Ogof3mFlggQ Video Video https://youtu.be/Ogof3mFlggQ https://www.hikma.com/who-we-are/leadership/ 2026-02-26T07:00:58Z https://www.hikma.com/who-we-are/leadership/victoria-hull/ 2026-03-05T15:05:54Z https://www.hikma.com/who-we-are/leadership/said-darwazah/ 2026-03-13T16:01:12Z https://www.hikma.com/who-we-are/leadership/mazen-darwazah/ 2026-03-17T10:50:01Z https://www.hikma.com/who-we-are/leadership/khalid-nabilsi/ 2026-03-13T15:45:01Z https://www.hikma.com/who-we-are/leadership/douglas-hurt/ 2026-03-05T15:05:02Z https://www.hikma.com/who-we-are/leadership/ali-al-husry/ 2026-03-13T15:49:09Z https://www.hikma.com/who-we-are/leadership/cynthia-flowers/ 2026-03-06T09:41:44Z https://www.hikma.com/who-we-are/leadership/laura-balan/ 2026-03-06T09:42:08Z https://www.hikma.com/who-we-are/leadership/dr-deneen-vojta/ 2026-03-13T16:04:20Z https://www.hikma.com/who-we-are/leadership/helen-middlemist/ 2024-02-12T16:32:31Z https://www.hikma.com/who-we-are/leadership/hussein-arkhagha/ 2026-03-18T09:51:46Z https://www.hikma.com/who-we-are/leadership/bassam-kanaan/ 2026-03-31T09:46:24Z https://www.hikma.com/who-we-are/leadership/susan-ringdal/ 2026-01-19T17:39:10Z https://www.hikma.com/who-we-are/leadership/hafrun-fridriksdottir/ 2026-03-05T15:07:59Z https://www.hikma.com/who-we-are/leadership/julie-hill/ 2026-03-13T16:18:25Z https://www.hikma.com/who-we-are/leadership/sam-park/ 2026-03-18T09:02:21Z https://www.hikma.com/who-we-are/history/ 2025-05-20T12:38:10Z https://www.hikma.com/who-we-are/corporate-governance/ 2026-03-18T09:57:52Z https://www.hikma.com/who-we-are/codes-and-standards/ 2024-11-25T15:43:40Z https://www.hikma.com/who-we-are/policy-positions/ 2026-04-02T13:12:54Z https://www.hikma.com/what-we-do/ 2026-03-23T12:42:31Z https://youtu.be/Z76x-2NuUbM Video Video https://youtu.be/-OHT2D_Yko0 Video Video https://youtu.be/uuSJtyWrEm0 Video Video https://youtu.be/Z76x-2NuUbM https://youtu.be/-OHT2D_Yko0 https://youtu.be/uuSJtyWrEm0 https://www.hikma.com/media/tzop2sbh/dummy.pdf https://www.hikma.com/what-we-do/our-businesses/ 2026-02-26T07:09:57Z https://youtu.be/4FVWZe8K6nM Video Video https://youtu.be/-OHT2D_Yko0 Video Video https://youtu.be/uuSJtyWrEm0 Video Video https://youtu.be/4FVWZe8K6nM https://youtu.be/-OHT2D_Yko0 https://youtu.be/uuSJtyWrEm0 https://www.hikma.com/media/tzop2sbh/dummy.pdf https://www.hikma.com/what-we-do/operations/ 2026-03-18T09:18:28Z https://youtu.be/-OHT2D_Yko0?si=3eXtG6SF_y2RJhGV Video Video https://youtu.be/6AfXctQuROs Video Video https://youtu.be/-OHT2D_Yko0?si=3eXtG6SF_y2RJhGV https://youtu.be/6AfXctQuROs https://www.hikma.com/what-we-do/rd/ 2026-03-18T09:19:47Z https://youtu.be/liDFbLc6UCM Video Video https://youtu.be/liDFbLc6UCM https://www.hikma.com/what-we-do/products/ 2025-08-01T08:02:34Z https://www.hikma.com/what-we-do/products/products-form/ 2024-11-25T16:43:33Z https://www.hikma.com/what-we-do/contract-manufacturing/ 2026-02-02T15:49:58Z https://youtu.be/e4XUi_c5unY Video Video https://youtu.be/C6d81GhnQ3k?si=aJSQ49d_PfG9yokN Video Video https://youtu.be/e4XUi_c5unY https://youtu.be/C6d81GhnQ3k?si=aJSQ49d_PfG9yokN https://www.hikma.com/what-we-do/contract-manufacturing/injectables/ 2026-02-02T15:09:59Z https://youtu.be/e4XUi_c5unY?si=eqNpYv24rMcLPqIs Video Video https://www.youtube.com/watch?v=VEf5HCjzmvA Video Video https://youtu.be/e4XUi_c5unY?si=eqNpYv24rMcLPqIs https://www.youtube.com/watch?v=VEf5HCjzmvA https://www.hikma.com/what-we-do/contract-manufacturing/hikma-rx/ 2026-02-02T15:10:47Z https://youtu.be/C6d81GhnQ3k?si=aJSQ49d_PfG9yokN Video Video https://youtu.be/C6d81GhnQ3k?si=aJSQ49d_PfG9yokN https://www.hikma.com/what-we-do/contract-manufacturing/contract-manufacturing-enquiries/ 2025-01-14T17:31:48Z https://www.hikma.com/what-we-do/partnering-with-hikma/ 2025-04-24T11:27:54Z https://www.hikma.com/what-we-do/hikma-ventures/ 2025-09-15T06:31:09Z https://www.hikma.com/what-we-do/commitment-to-quality/ 2024-05-21T09:26:44Z https://www.hikma.com/media/tzop2sbh/dummy.pdf https://www.hikma.com/responsibility/ 2026-03-18T09:21:37Z https://youtu.be/nSjn9bOugJ8 Video Video https://youtu.be/nSjn9bOugJ8 https://www.hikma.com/responsibility/advancing-health-and-wellbeing/ 2025-06-30T10:48:35Z https://www.hikma.com/responsibility/advancing-health-and-wellbeing/access-to-medicines/ 2026-03-18T09:27:55Z https://www.hikma.com/responsibility/advancing-health-and-wellbeing/product-quality-and-safety/ 2025-11-24T12:37:17Z https://youtu.be/BfhNfhtty-I?si=IRaHpbeFkcJv5zPa Video Video https://youtu.be/BfhNfhtty-I?si=IRaHpbeFkcJv5zPa https://www.hikma.com/responsibility/empowering-our-people/ 2025-12-16T14:43:46Z https://www.hikma.com/responsibility/protecting-the-environment/ 2025-06-30T10:48:47Z https://youtu.be/3SD_Tb4YYSM Video Video https://youtu.be/DOHTSnM7ETc Video Video https://youtu.be/3SD_Tb4YYSM https://youtu.be/DOHTSnM7ETc https://www.hikma.com/responsibility/upholding-ethical-standards-and-acting-with-integrity/ 2025-06-30T10:48:51Z https://www.hikma.com/responsibility/partnerships-stakeholders/ 2026-01-21T16:49:34Z https://www.hikma.com/responsibility/awards-and-recognition/ 2026-01-12T16:32:43Z https://www.hikma.com/responsibility/suppliers/ 2025-12-22T09:22:03Z https://www.hikma.com/responsibility/sustainability-reports/ 2025-06-30T10:48:54Z https://www.hikma.com/media/32hpzshb/hikma_sr2024.pdf https://www.hikma.com/media/unxpgids/hikma_sr2023.pdf https://www.hikma.com/media/gldecw0t/hikma-sr-2022_interactive_190523.pdf https://www.hikma.com/media/ol4emb04/sr2021-may-12-2022-final.pdf https://www.hikma.com/media/ztvd2yqv/hikma-sustainability-report-and-cop-2020.pdf https://www.hikma.com/acting-responsibly/ 2026-03-18T09:34:29Z https://youtu.be/t1ToJkcpMJQ Video Video https://youtu.be/t1ToJkcpMJQ https://www.hikma.com/investors/ 2026-03-18T10:39:01Z https://www.youtube.com/watch?v=szHU8os8Am0 Video Video https://www.youtube.com/watch?v=szHU8os8Am0 https://www.hikma.com/investors/recent-results/ 2026-03-18T10:39:06Z https://www.hikma.com/investors/why-invest/ 2026-02-26T12:35:22Z https://www.hikma.com/investors/strategy/ 2025-09-05T12:18:40Z https://www.hikma.com/investors/results-and-presentations/ 2026-03-18T09:02:30Z https://www.hikma.com/media/wsnfgf3v/1-2025-annual-report.pdf https://www.hikma.com/media/etij3sft/hikma-pharmaceuticals-plc-2025-full-year-results-combined-press-release-vfinal.pdf https://www.hikma.com/media/d54itxkb/hikma-pharmaceuticals-plc-2025-fy-presentation-vfinal-260226.pdf https://www.hikma.com/media/jhupjyw5/hikma-pharmaceuticals-plc-2025-fy-results-presentation-transcript-260226.pdf https://www.hikma.com/media/w4kfdvlf/hikma-pharmaceuticals-management-qa-transcript-fyr25.pdf https://www.hikma.com/media/cnuhonos/analyst-aide-memoire-dec-2025.pdf https://www.hikma.com/media/bovfobyd/jefferies-healthcare-conference-2025-transcript.pdf https://www.hikma.com/media/ltgiidnm/november-2025-trading-update-vfinal-2.pdf https://www.hikma.com/media/3ouhrxem/transcript-hikma-november-trading-update-06112025.pdf https://www.hikma.com/media/m2hebmry/hikma-2025-interim-results-pr-07-aug-2025.pdf https://www.hikma.com/media/5nyls5gx/hikma-2025-interim-results-presentation-07-aug-2025.pdf https://www.hikma.com/media/aqjj21vx/hikma-2025-interim-results-presentation-transcript-07-aug-2025.pdf https://www.hikma.com/media/x0odsmrm/hikma_2025_interim_results_qa_transcript_07082025.pdf https://www.hikma.com/media/o3wnxli5/analyst-aide-memoire-jun-2025-vfinal.pdf https://www.hikma.com/media/f42jl5qj/us-investor-event-may-2025-final-presentation-for-website.pdf https://www.hikma.com/media/nnwfxjk1/2025_hikma_investorsday_transcript_edited-pdf-1.pdf https://www.hikma.com/media/5zfnzs0s/april-2025-trading-update-vfinal.pdf https://www.hikma.com/media/coic5yur/hikma-april-2025-trading-update-qa-transcript.pdf https://www.hikma.com/media/bt5ngmh1/hikma-annual-report-2024.pdf https://www.hikma.com/media/jirfeccg/combined-2024-press-release-and-bfr-vfinal.pdf https://www.hikma.com/media/05enpftu/fy-2024-presentation-vfinal.pdf https://www.hikma.com/media/bzrhiht4/2024-preliminary-results-presentation-transcript.pdf https://www.hikma.com/media/dpkfemu5/hikma_fy24_results_transcript-260225.pdf https://www.hikma.com/media/cnrnyyxh/2025-jpm-conference-presentation.pdf https://www.hikma.com/media/5ssni24c/jpm-2025-conference-presentation-and-qa-transcript.pdf https://www.hikma.com/media/1u2besjf/analyst-aide-memoire-dec-2024-vfinal.pdf https://www.hikma.com/media/osahswdk/jefferies-healthcare-conference-2024-qa-transcript-1.pdf https://www.hikma.com/media/bcunv0r4/hikma-casablanca-site-visit-november-2024-presentation.pdf https://www.hikma.com/media/ygcj3ihv/hikma-mena-meet-the-management-presentation-and-qa-transcript.pdf https://www.hikma.com/media/yxnbbqbh/november-2024-trading-update-vfinal.pdf https://www.hikma.com/media/qzjklnka/hikma-november-2024-trading-update-qa-transcript.pdf https://www.hikma.com/media/ul4ifnxb/2024-interim-press-release-vfinal-combined.pdf https://www.hikma.com/media/orupxfg1/1h24-presentation-v3.pdf https://www.hikma.com/media/mwjhi2af/2024-interim-results-presentation-transcript.pdf https://www.hikma.com/media/sj1i3lu0/hikma-2024-interim-results-qa-transcript.pdf https://www.hikma.com/media/fbzb4ccu/xellia-asset-acquisition-qa-transcript-v2.pdf https://www.hikma.com/media/e1qkpxwi/april-2024-trading-update-vfinal.pdf https://www.hikma.com/media/dxmn5ukn/hikma-april-trading-update-qa-transcript_2542024.pdf https://www.hikma.com/media/ex1jgvy1/hikma-2023-full-annual-report.pdf https://www.hikma.com/media/10ib0usi/2023-press-release-and-bfr-vfinal-combined.pdf https://www.hikma.com/media/orvgts4s/2023-fy-presentation-v3.pdf https://www.hikma.com/media/yhogapvc/2023-full-year-results-presentation-transcripts.pdf https://www.hikma.com/media/cbnhlwny/hikma-2024-feb-22-transcript.pdf https://www.hikma.com/media/y5zpwssf/jpm-conference-2024-presentation-vfinal.pdf https://www.hikma.com/media/h4ymg5fa/combined-2023-interim-press-release-vfinal.pdf https://www.hikma.com/media/pj1p3har/1h23-presentation-v2.pdf https://www.hikma.com/media/bxenlk3r/2023-interim-presentation-transcript.pdf https://www.hikma.com/media/sqbimecw/hikma-3august2023-transcript.pdf https://www.hikma.com/media/nxxpgje1/hikma_ar2022_full.pdf https://www.hikma.com/media/0dwp1zxd/combined-2022-press-release-and-bfr-vfinal.pdf https://www.hikma.com/media/ndvf3gx3/2022-full-year-results-presentation-vfinal.pdf https://www.hikma.com/media/shffvtrd/2022-results-presentation-transcript.pdf https://www.hikma.com/media/xmhfpojf/hikma-preliminary-results-2022-call-transcript.pdf https://www.hikma.com/media/iunfqmpw/jpm-2023-presentation-vfinal.pdf https://www.hikma.com/media/q4xideom/injectable-portugal-site-visit-presentation.pdf https://www.hikma.com/media/ismbcvck/2022-interim-press-release-vfinal.pdf https://www.hikma.com/media/qu5mesvd/2022-interims-presentation-vfinal.pdf https://www.hikma.com/media/gmtpv2cl/h1-2022-presentation-transcript-for-website.pdf https://www.hikma.com/media/c0vhgbcx/qa-transcripts.pdf https://www.hikma.com/media/ixgmzuqj/hikma_ara_2021_full-interactive.pdf https://www.hikma.com/media/gx1do0zg/2021-press-release-and-bfr-vfinal.pdf https://www.hikma.com/media/podd0z3v/2021fy-presentation-vfinal.pdf https://www.hikma.com/media/eetbsewh/hikma-preliminary-results-conference-call-transcript.pdf https://www.hikma.com/media/4o1am313/jpm-2022-conference-presentation-v6-final.pdf https://www.hikma.com/media/kj0m3b3d/2021-interim-press-release-vfinal.pdf https://www.hikma.com/media/5ekdhwvk/2021-interim-presentation-vfinal.pdf https://www.hikma.com/media/0akiox33/2020-full-ar.pdf https://www.hikma.com/media/khupcgyk/2020-combined-press-release-and-bfr-vfinal.pdf https://www.hikma.com/media/c2gdm41z/2020-fy-presentation-vfinal.pdf https://www.hikma.com/media/wjgpyoiy/combined-2020-interim-press-release-vfinal.pdf https://www.hikma.com/media/t1lfqd1u/2020-interim-presentation-vfinal.pdf https://www.hikma.com/media/ylkpxepl/jpm-conference-presentation-vfinal.pdf https://www.hikma.com/media/r0wfkmqg/injectables-mtm-presentation-vfinal.pdf https://www.hikma.com/media/v4np4q0u/branded-mtm-presentation-v12.pdf https://www.hikma.com/media/tt0nclav/generics-meet-the-management-sep-2021-transcript.pdf https://www.hikma.com/media/cctphgav/generics-mtm-presentation_v21-final.pdf https://www.hikma.com/media/uiwnvyy3/2019-full-ar.pdf https://www.hikma.com/media/wvybsii5/2019-full-year-presentation-v10-final-2.pdf https://www.hikma.com/media/kk1pcxsu/press-release-v19-final.pdf https://www.hikma.com/media/efinsugz/38th-annual-jp-morgan-healthcare-conference-presentation.pdf https://www.hikma.com/media/2gubpzhb/combined-press-release-v13-final.pdf https://www.hikma.com/media/2sydcwkf/2019-interim-presentation-final.pdf https://www.hikma.com/media/2kgh5bw5/hikma_ar2018_full-ar.pdf https://www.hikma.com/media/ngopamcz/fy-2018-presentation-final.pdf https://www.hikma.com/media/1c2pfobc/ey-2018-results-press-release.pdf https://www.hikma.com/media/3nagvkgo/investor-day-presentation-final-v1.pdf https://www.hikma.com/media/5lspnrh5/interim-results-presentation-final.pdf https://www.hikma.com/media/1mid5tii/hikma-h1-2018-press-release-combined.pdf https://www.hikma.com/media/ysblktmx/hikma-h1-2017-interim-presentation.pdf https://www.hikma.com/media/b1mjoy4v/hikma-delivers-stable-profitability-and-strong-cash-generation-in-h1-and-maintains-a-solid-balance-sheet-2.pdf https://www.hikma.com/media/wyfbrs1v/hikma-ar-2017.pdf https://www.hikma.com/media/1i4l3rst/fy-2017-presentation-final-2.pdf https://www.hikma.com/media/pvcbatyb/hikma-reports-2017-full-year-results-003.pdf https://www.hikma.com/media/bk3bcvw2/2016-preliminary-results.pdf https://www.hikma.com/media/ayza50el/hikma-delivers-a-solid-financial-performance-in-2016-and-makes-significant-strategic-progress.pdf https://www.hikma.com/media/4b2dzilf/2016-annual-report.pdf https://www.hikma.com/media/ohlnn0ca/h1-2016-interim-presentation.pdf https://www.hikma.com/media/qhlf4urk/h1-2016-interim-results-press-release.pdf https://www.hikma.com/media/nvlhangk/meet-the-management-presentation-1.pdf https://www.hikma.com/media/s50hmf1g/mtmd-save-the-date-sept-2016-vfinal.pdf https://www.hikma.com/media/hujbf2fl/2015-roxane-laboratories-acquisition-presentation.pdf https://www.hikma.com/media/221decxf/2015-roxane-laboratories-acquisition-press-release.pdf https://www.hikma.com/media/2bumodaj/2015-interim-results-1.pdf https://www.hikma.com/media/30ybeccs/2015-interim-press-release.pdf https://www.hikma.com/media/lcjda1id/2015-preliminary-results-presentation-16-march-v2.pdf https://www.hikma.com/media/bbbmjpq4/2015-preliminary-results-press-release.pdf https://www.hikma.com/media/nhkmiuix/hikma-2015-annual-report-final.pdf https://www.hikma.com/media/n1jkjzwu/2014-annual-report.pdf https://www.hikma.com/media/kpan1rxp/2014-prelim-results-presentation.pdf https://www.hikma.com/media/lbyfuwqf/2014-prelim-press-release.pdf https://www.hikma.com/investors/regulatory-news/ 2024-03-22T14:43:22Z https://www.hikma.com/investors/regulatory-news/email-alert-sign-up/ 2024-04-26T15:08:56Z https://www.hikma.com/investors/company-compiled-consensus/ 2026-03-25T14:57:47Z https://www.hikma.com/investors/company-compiled-consensus/analyst-coverage/ 2026-03-25T10:26:00Z https://www.hikma.com/investors/financial-calendar/ 2026-01-07T12:29:27Z https://www.hikma.com/investors/investor-tools/ 2024-02-14T11:45:32Z https://www.hikma.com/investors/investor-tools/share-price-lookup/ 2024-03-20T09:39:08Z https://www.hikma.com/investors/investor-tools/share-graph/ 2024-03-20T10:02:47Z https://www.hikma.com/investors/investor-tools/share-series/ 2024-03-22T14:54:47Z https://www.hikma.com/investors/investor-tools/investment-calculator/ 2024-03-22T14:56:27Z https://www.hikma.com/investors/shareholder-information/ 2025-01-28T11:20:21Z https://www.hikma.com/investors/shareholder-information/manage-your-shareholding/ 2025-12-15T09:25:22Z https://www.hikma.com/investors/shareholder-information/shareholder-meetings/ 2026-03-18T09:02:48Z https://www.hikma.com/media/txgjqum2/5-agm-2026-notice.pdf https://www.hikma.com/media/wuamypkw/6-consent-letter-by-citi-redacted.pdf https://www.hikma.com/media/w4jjlnby/7-r9-waiver-faqs.pdf https://www.hikma.com/media/c4tbquxq/hikma-ar24-nom.pdf https://www.hikma.com/media/gyvhfbbn/hikma-agm-2025-consent-letter-executed-by-citi-13-mar-2025.pdf https://www.hikma.com/media/wdmdav0t/hikma-agm-2025-rule-9-waiver-faqs.pdf https://www.hikma.com/media/wx4h3tw2/250424-final-results-of-agm.pdf https://www.hikma.com/media/xlohluxg/hikma_nom-2024.pdf https://www.hikma.com/media/dwvbd3ln/210423-plc-articles-of-association-2021-with-date.pdf https://www.hikma.com/media/iwzlk30l/16-citi-consent-letter-13-march-2024_redacted.pdf https://www.hikma.com/media/lwkkbpay/240425-final-results-of-agm.pdf https://www.hikma.com/media/o0vlf3cp/hikma_agm-2023_nom.pdf https://www.hikma.com/media/1dhliect/hikma-pharmaceuticals-agm-virtual-attendance-user-guide.pdf https://www.hikma.com/media/ed4p30if/results-of-our-agm-2023.pdf https://www.hikma.com/media/blcbrtd2/notice-of-egm-creation-of-distributable-reserves-resolution-v4-final.pdf https://www.hikma.com/media/gh2fdxaf/results-of-egm-2022.pdf https://www.hikma.com/media/g1wpy5lr/hikma_ara_2021_notice_of_annual_general_meeting.pdf https://www.hikma.com/media/rl3d23wl/hikma-agm-document-final.pdf https://www.hikma.com/media/rg4plr5f/results-of-agm-2022.pdf https://www.hikma.com/media/yrli0wy2/hikma_ar2020_notice_of_meeting_web.pdf https://www.hikma.com/media/qgibz32o/plc-articles-of-association-2021-to-propose-to-shareholders-apr-2021.doc https://www.hikma.com/media/riohnzui/210423-results-of-agm.pdf https://www.hikma.com/media/ivyhnwm2/agm-change-of-venue-rr.pdf https://www.hikma.com/media/sgwibd3o/hikma_ar2019_notice_of_meeting.pdf https://www.hikma.com/media/emrbig2t/133357-hikma-virtual-meeting-communication-2020.pdf https://www.hikma.com/media/5bjfxvom/200430-results-of-agm.pdf https://www.hikma.com/media/3xulbuwj/190517-results-of-agm-v1.pdf https://www.hikma.com/media/mmphocfk/final-notice-of-meeting-2018.pdf https://www.hikma.com/media/squkopaw/hikma-agm-update.pdf https://www.hikma.com/media/yj4g5rhd/2017_noticeofmeeting_hikma.pdf https://www.hikma.com/media/fgjpmxmi/170519-results-of-agm-v3.pdf https://www.hikma.com/media/lecheuum/agm-notice-and-circular-2016-final.pdf https://www.hikma.com/media/jhhdtdqx/160512-results-of-agm.pdf https://www.hikma.com/media/bhybqjke/circular-and-prospectus_.pdf https://www.hikma.com/media/cxxmfhnz/supplementary-circular_.pdf https://www.hikma.com/media/qv2m0izn/results-of-egm.pdf https://www.hikma.com/media/z51deig1/agm-notice-2015.pdf https://www.hikma.com/media/kgdhniez/agm-voting-results-2015.pdf https://www.hikma.com/media/51rm1nlt/agm-notice-2014.pdf https://www.hikma.com/media/4p1p5hko/results-of-agm-2014.pdf https://www.hikma.com/media/pd2ps0f5/agm-notice-2013.pdf https://www.hikma.com/media/tcufs1hx/results-agm-2013.pdf https://www.hikma.com/media/kvbeyprw/agm-notice-2012.pdf https://www.hikma.com/media/5luh101q/results-of-agm-12.pdf https://www.hikma.com/media/xwkbklvi/latest-agm-notice.pdf https://www.hikma.com/media/w42fcvcm/voting-results-2011.pdf https://www.hikma.com/media/5rvdkb2e/agm-notice-2010.pdf https://www.hikma.com/media/2lynrz4e/results-of-agm-vfinal-2010.pdf https://www.hikma.com/media/prafdu2q/agm-notice-2009.pdf https://www.hikma.com/media/pvhjzixv/results-of-agm-2009.pdf https://www.hikma.com/media/o2fefzzu/agm-notice-2008.pdf https://www.hikma.com/media/s0sb1srv/results-of-agm-2008.pdf https://www.hikma.com/media/qmtcydgn/agm-notice-2007.pdf https://www.hikma.com/media/irubzopc/results-of-agm-2007.pdf https://www.hikma.com/media/2c4lxeyr/agm-notice-2006-final.pdf https://www.hikma.com/media/lnkhtj44/results_of_agm-2006.pdf https://www.hikma.com/investors/shareholder-information/dividend-information/ 2025-12-10T12:48:06Z https://www.hikma.com/investors/shareholder-information/share-listings-and-depositary-receipts/ 2024-01-24T09:36:29Z https://www.hikma.com/investors/2025-annual-report/ 2026-03-18T09:06:40Z https://www.hikma.com/investors/corporate-factsheets/ 2026-02-26T16:09:43Z https://www.hikma.com/careers/ 2025-11-20T13:42:14Z https://www.hikma.com/careers/search-jobs/ 2024-01-25T11:29:05Z https://www.hikma.com/careers/roles-at-hikma/ 2025-11-24T16:41:12Z https://www.hikma.com/careers/why-hikma/ 2026-03-11T12:45:30Z https://www.hikma.com/news/ 2026-01-06T14:13:58Z https://www.hikma.com/news/hikma-expands-its-agreement-with-aft-pharmaceuticals-for-the-commercialisation-of-injectable-pain-medication-combogesic-into-the-saudi-jordanian-and-iraqi-markets/ 2024-08-31T02:20:42Z https://www.hikma.com/news/hikma-and-guardant-health-sign-exclusive-partnership-agreement-to-bring-transformative-cancer-diagnostic-technology-to-the-middle-east-and-north-africa/ 2024-02-12T17:49:06Z https://www.hikma.com/news/hikma-launches-authorized-generic-of-xyrem-sodium-oxybate-in-the-us/ 2024-04-16T16:16:58Z https://www.hikma.com/news/hikma-and-celltrion-healthcare-sign-new-exclusive-licensing-agreement-for-vegzelma-for-the-middle-east-and-north-africa-region/ 2024-04-16T16:21:45Z https://www.hikma.com/news/hikma-expands-addiction-therapy-portfolio-with-the-launch-of-naloxone-hydrochloride-injection-usp-in-prefilled-syringe/ 2024-02-09T17:40:10Z https://www.hikma.com/news/hikma-to-present-at-41st-annual-jp-morgan-healthcare-conference/ 2024-04-16T16:22:21Z https://www.hikma.com/news/notice-of-preliminary-results/ 2024-02-12T18:08:35Z https://www.hikma.com/news/hikma-delivers-a-resilient-underlying-performance-in-2022/ 2024-04-16T16:22:54Z https://www.hikma.com/news/hikma-expands-impact-in-canada-with-launches-of-new-sterile-injectable-medicines/ 2024-04-16T16:23:06Z https://www.hikma.com/news/hikma-launches-cefazolin-for-injection-usp-in-the-us/ 2024-04-16T16:23:20Z https://www.hikma.com/news/hikma-launches-icosapent-ethyl-capsules-05g-in-the-us/ 2024-04-16T16:23:39Z https://www.hikma.com/news/hikma-launches-labetalol-hydrochloride-injection-usp-in-prefilled-syringe/ 2024-04-16T16:24:02Z https://www.hikma.com/news/hikma-launches-posaconazole-oral-suspension-in-the-us/ 2024-04-16T16:25:27Z https://www.hikma.com/news/riad-mishlawi-named-chief-executive-officer-of-hikma-pharmaceuticals-plc/ 2024-12-16T09:45:48Z https://www.hikma.com/news/hikma-launches-regadenoson-injection-in-prefilled-syringe/ 2024-04-16T16:26:04Z https://www.hikma.com/news/good-momentum-across-all-businesses-and-updated-generics-guidance/ 2024-04-16T16:26:21Z https://www.hikma.com/news/hikma-launches-diazepam-injection-usp-in-the-us/ 2024-04-16T16:26:39Z https://www.hikma.com/news/hikma-exceeds-150-injectable-medicines-in-the-us-with-launch-of-dobutamine-injection-usp/ 2024-02-12T18:05:25Z https://www.hikma.com/news/hikma-launches-neostigmine-methylsulfate-injection-usp-in-prefilled-syringe/ 2024-04-16T16:27:02Z https://www.hikma.com/news/hikma-launches-midazolam-in-09-sodium-chloride-injection-in-the-us/ 2024-04-16T16:27:16Z https://www.hikma.com/news/notice-of-results/ 2024-04-16T16:27:31Z https://www.hikma.com/news/hikma-appoints-new-president-of-injectables-business/ 2024-12-16T09:39:22Z https://www.hikma.com/news/hikma-and-rakuten-medical-sign-exclusive-licensing-agreement-for-alluminoxtm-platform-cancer-treatment-for-the-middle-east-and-north-africa/ 2024-04-16T16:27:53Z https://www.hikma.com/news/hikma-launches-new-503b-sterile-compounding-business/ 2024-04-16T16:28:12Z https://www.hikma.com/news/hikma-to-present-at-40th-annual-jp-morgan-healthcare-conference/ 2024-04-16T16:28:28Z https://www.hikma.com/news/hikma-expands-into-canada-with-acquisition-of-teligent-sterile-injectable-assets/ 2024-04-16T16:28:45Z https://www.hikma.com/news/hikma-ventures-leads-series-a-extension-in-nuvoair-to-support-its-platform-for-patient-centric-care-and-clinical-trials/ 2024-04-16T16:29:00Z https://www.hikma.com/news/hikma-signs-license-agreement-with-medicine-patent-pool-for-molnupiravir/ 2024-04-16T16:29:16Z https://www.hikma.com/news/hikma-launches-diazepam-injection-usp-in-single-dose-prefilled-syringe/ 2024-04-16T16:29:33Z https://www.hikma.com/news/hikma-completes-acquisition-of-teligent-sterile-injectable-assets/ 2024-04-16T16:29:51Z https://www.hikma.com/news/hikma-expands-licensing-agreement-with-celltrion-for-remsima-subcutaneous-formulation-in-mena/ 2024-04-16T16:30:06Z https://www.hikma.com/news/notice-of-preliminary-results-1/ 2024-02-12T16:25:05Z https://www.hikma.com/news/hikma-delivers-another-year-of-profitable-growth-in-2021-and-announces-share-buyback/ 2024-02-09T17:49:35Z https://www.hikma.com/news/hikma-ventures-leads-series-b-extension-in-activ-surgical-to-support-the-global-commercialization-of-its-platform/ 2024-04-16T16:30:34Z https://www.hikma.com/news/hikma-launches-benztropine-mesylate-injection-usp/ 2024-04-16T16:30:50Z https://www.hikma.com/news/hikma-ventures-participates-in-usd-44-million-financing-round-for-altibbi-to-expand-the-platform-s-reach-across-mena/ 2024-04-23T17:39:36Z https://www.hikma.com/news/hikma-ventures-invests-in-tactai-an-ai-powered-customer-engagement-platform-for-life-sciences-companies/ 2024-04-23T17:39:44Z https://www.hikma.com/news/hikma-ventures-leads-seed-financing-round-for-egypt-based-o7-therapy-a-mental-health-service-provider-for-arabic-speakers-worldwide/ 2024-04-23T17:39:56Z https://www.hikma.com/news/hikma-confirms-ftc-preliminary-approval-for-custopharm/ 2024-02-09T17:51:41Z https://www.hikma.com/news/hikma-completes-acquisition-of-custopharm/ 2024-02-09T17:51:56Z https://www.hikma.com/news/continued-strategic-progress-and-updated-full-year-guidance-following-custopharm-acquisition/ 2024-02-12T16:22:25Z https://www.hikma.com/news/hikma-updates-generics-guidance-for-2022/ 2024-04-23T17:40:30Z https://www.hikma.com/news/siggi-olafsson-to-step-down-as-chief-executive/ 2024-04-23T17:40:37Z https://www.hikma.com/news/section-430-2b-companies-act-2006-statement/ 2024-04-23T17:40:51Z https://www.hikma.com/news/hikma-enters-the-french-generic-injectables-market-expanding-european-presence/ 2024-02-09T17:45:25Z https://www.hikma.com/news/hikma-and-celltrion-sign-exclusive-licensing-agreement-for-yuflymatm-for-the-middle-east-and-north-africa-region/ 2024-02-09T17:48:14Z https://www.hikma.com/news/notice-of-results-1/ 2024-02-09T17:55:52Z https://www.hikma.com/news/hikma-s-diversified-business-delivers-resilient-h1-performance/ 2024-04-16T16:32:22Z https://www.hikma.com/news/hikma-launches-ryaltris-seasonal-allergic-rhinitis-nasal-spray-in-the-us/ 2024-04-16T16:32:34Z https://www.hikma.com/news/hikma-launches-bortezomib-for-injection/ 2024-02-12T16:23:12Z https://www.hikma.com/news/hikma-launches-fulvestrant-injection/ 2024-04-16T16:33:02Z https://www.hikma.com/news/hikma-appoints-victoria-hull-and-laura-balan-as-directors/ 2024-04-16T16:33:16Z https://www.hikma.com/news/hikma-appoints-deneen-vojta-md-as-a-director/ 2024-02-09T17:41:22Z https://www.hikma.com/news/hikma-launches-first-prefilled-syringe-of-succinylcholine-chloride-injection-usp/ 2024-04-16T16:33:35Z https://www.hikma.com/news/hikma-reiterates-full-year-segmental-guidance-with-strong-momentum-in-injectables-and-branded/ 2024-04-16T16:33:51Z https://www.hikma.com/news/hikma-and-celltrion-healthcare-sign-exclusive-licensing-agreement-for-ustekinumab-for-the-middle-east-and-north-africa-region/ 2024-04-16T16:34:01Z https://www.hikma.com/news/hikma-injectables-portugal-site-visit/ 2024-04-16T16:34:11Z https://www.hikma.com/news/hikma-launches-levothyroxine-sodium-injection-in-ready-to-use-vials/ 2024-04-16T16:34:25Z https://www.hikma.com/news/hikma-and-junshi-biosciences-sign-exclusive-licensing-agreement-for-cancer-treatment-drug-toripalimab-for-the-middle-east-and-north-africa-region/ 2024-04-16T16:34:36Z https://www.hikma.com/news/hikma-s-commitment-to-environmental-performance-recognised-with-a-rating-in-2020-cdp-global-climate-change-report/ 2024-04-16T16:34:45Z https://www.hikma.com/news/hikma-provides-update-on-generic-advair-diskus-launch/ 2024-04-16T16:34:54Z https://www.hikma.com/news/potential-acquisition/ 2024-04-16T16:35:06Z https://www.hikma.com/news/hikma-participates-in-the-virtual-51st-world-economic-forum-annual-meeting/ 2024-04-16T16:35:17Z https://www.hikma.com/news/hikma-launches-ephedrine-sulfate-injection-usp/ 2024-04-16T16:35:43Z https://www.hikma.com/news/notice-of-preliminary-results-2/ 2024-02-12T14:43:22Z https://www.hikma.com/news/hikma-launches-thiamine-hydrochloride-injection-usp/ 2024-04-16T16:36:02Z https://www.hikma.com/news/hikma-donates-over-4-million-usd-in-medicines-and-signs-new-long-term-partnerships-with-dispensary-of-hope-direct-relief-americares-brother-s-brother-foundation-and-the-national-children-s-cancer-society/ 2024-04-16T16:36:13Z https://www.hikma.com/news/hikma-delivers-strong-performance-in-2020/ 2024-04-16T16:36:25Z https://www.hikma.com/news/reminder-analyst-and-investor-live-qa-call/ 2024-04-16T16:36:37Z https://www.hikma.com/news/meet-the-management-series/ 2024-04-16T16:36:50Z https://www.hikma.com/news/hikma-launches-generic-version-of-northera/ 2024-04-16T16:37:03Z https://www.hikma.com/news/hikma-and-gsk-agree-to-cease-potential-acquisition-discussions-in-egypt-and-tunisia/ 2024-04-16T16:37:13Z https://www.hikma.com/news/reminder-injectables-meet-the-management-24-march-2021-200pm-to-330pm/ 2024-04-16T16:37:23Z https://www.hikma.com/news/hikma-pledges-additional-40-000-to-local-us-food-banks-and-pantries-in-fight-against-hunger/ 2024-04-16T16:37:34Z https://www.hikma.com/news/hikma-resumes-launch-of-generic-advair-diskus/ 2024-04-16T16:37:44Z https://www.hikma.com/news/hikma-announces-exclusive-agreement-with-aft-pharmaceuticals-for-injectable-non-opioid-pain-medication-combogesic-iv-in-the-us/ 2024-04-16T16:37:53Z https://www.hikma.com/news/hikma-and-melinta-therapeutics-sign-exclusive-licensing-agreement-for-two-novel-anti-infectives-for-the-middle-east-and-north-africa-region/ 2024-04-16T16:38:04Z https://www.hikma.com/news/hikma-announces-good-start-to-2021-and-reiterates-full-year-guidance/ 2024-04-16T16:41:12Z https://www.hikma.com/news/hikma-announces-us-fda-approval-of-kloxxado-tm-naloxone-hydrochloride-nasal-spray-8mg/ 2024-04-16T16:41:23Z https://www.hikma.com/news/hikma-launches-dexmedetomidine-hydrochloride-in-09-sodium-chloride-injection/ 2024-04-16T16:41:34Z https://www.hikma.com/news/hikma-launches-docetaxel-injection-usp/ 2024-04-16T16:41:45Z https://www.hikma.com/news/hikma-launches-hydralazine-hydrochloride-injection-usp/ 2024-04-16T16:41:55Z https://www.hikma.com/news/meet-the-management-series-branded/ 2024-04-16T16:42:06Z https://www.hikma.com/news/hikma-launches-labetalol-hydrochloride-injection-in-ready-to-use-bags/ 2024-04-16T16:42:16Z https://www.hikma.com/news/hikma-launches-estradiol-valerate-injection-usp/ 2024-04-16T16:42:26Z https://www.hikma.com/news/hikma-appoints-patrick-genestin-to-lead-generics-business-development/ 2024-04-16T16:42:38Z https://www.hikma.com/news/reminder-branded-meet-the-management-22-june-2021-200pm-to-300pm/ 2024-04-16T16:42:46Z https://www.hikma.com/news/hikma-launches-ganciclovir-for-injection-usp/ 2024-04-16T16:42:59Z https://www.hikma.com/news/hikma-launches-rufinamide-tablets/ 2024-04-16T16:43:08Z https://www.hikma.com/news/hikma-launches-doxycycline-for-injection/ 2024-04-16T16:43:17Z https://www.hikma.com/news/hikma-launches-succinylcholine-chloride-injection-usp/ 2024-04-16T16:43:29Z https://www.hikma.com/news/notice-of-results-2/ 2024-04-16T16:43:43Z https://www.hikma.com/news/hikma-announces-us-launch-of-kloxxadotm-naloxone-hcl-nasal-spray-8mg/ 2024-04-16T16:43:52Z https://www.hikma.com/news/hikma-delivers-another-strong-financial-and-operational-performance-and-improves-fy-outlook-for-generics/ 2024-04-16T16:44:09Z https://www.hikma.com/news/meet-the-management-series-generics/ 2024-04-16T16:44:20Z https://www.hikma.com/news/bio-thera-solutions-and-hikma-pharmaceuticals-announce-exclusive-commercialization-and-license-agreement-for-bat2206-in-the-us-a-proposed-biosimilar-referencing-stelara-ustekinumab/ 2024-04-16T16:44:35Z https://www.hikma.com/news/hikma-and-faes-farma-enter-into-exclusive-licensing-agreement-for-the-commercialisation-of-bilastine-tablets-in-the-us/ 2024-04-16T16:44:46Z https://www.hikma.com/news/reminder-generics-meet-the-management-23-september-2021-200pm-to-315pm/ 2024-04-16T16:44:56Z https://www.hikma.com/news/hikma-strengthens-us-injectables-business-through-acquisition-of-custopharm/ 2024-04-16T16:45:05Z https://www.hikma.com/news/hikma-launches-micafungin-for-injection/ 2024-04-16T16:46:12Z https://www.hikma.com/news/hikma-donates-50-000-doses-of-injectable-naloxone-to-help-expand-non-profit-access-to-lifesaving-treatment-for-reversing-opioid-overdoses/ 2024-04-16T16:46:23Z https://www.hikma.com/news/hikma-and-almirall-enter-an-exclusive-licensing-agreement-to-market-finjuve-in-the-middle-east-and-north-africa-region/ 2024-04-16T16:46:32Z https://www.hikma.com/news/hikma-continues-strong-2021-performance-and-reiterates-full-year-guidance/ 2024-04-16T16:46:43Z https://www.hikma.com/news/hikma-ventures-invests-in-biotechnology-company-biosapien-inc-developer-of-a-patented-drug-delivery-device-intended-to-reduce-the-system-wide-side-effects-of-chemotherapy-treatments/ 2024-04-16T16:46:53Z https://www.hikma.com/news/richter-and-hikma-sign-exclusive-commercialisation-and-license-agreement-for-denosumab-in-the-us-a-proposed-biosimilar-referencing-prolia-and-xgeva/ 2024-04-16T16:47:05Z https://www.hikma.com/news/hikma-launches-bupivacaine-hcl-injection-usp/ 2024-04-16T16:47:15Z https://www.hikma.com/news/hikma-further-improves-its-environmental-performance-in-2019-cdp-global-climate-change-report/ 2024-02-12T16:24:18Z https://www.hikma.com/news/notice-of-preliminary-results-3/ 2024-02-12T16:25:49Z https://www.hikma.com/news/hikma-and-glenmark-pharmaceuticals-enter-into-exclusive-licensing-agreement-for-commercialising-ryaltris-seasonal-allergic-rhinitis-nasal-spray-in-the-us/ 2024-04-16T16:47:38Z https://www.hikma.com/news/hikma-delivers-strong-growth-in-revenue-and-profit-in-2019/ 2024-02-12T16:26:41Z https://www.hikma.com/news/hikma-pharmaceuticals-usa-inc-extends-voluntary-nationwide-recall-of-ketorolac-tromethamine-injection-usp-30mgml-1ml-fill2ml-vials-due-to-the-potential-presence-of-small-particulates/ 2024-04-16T16:48:01Z https://www.hikma.com/news/hikma-expands-generics-portfolio-with-everolimus-tablets-launch/ 2024-04-16T16:48:12Z https://www.hikma.com/news/hikma-supports-teachers-in-jordan-through-new-partnership-with-save-the-children/ 2024-04-16T16:48:22Z https://www.hikma.com/news/hikma-update-regarding-covid-19/ 2024-02-12T16:08:56Z https://www.hikma.com/news/hikma-launches-vecuronium-bromide-for-injection/ 2024-04-16T16:48:47Z https://www.hikma.com/news/hikma-announces-strong-start-to-2020-and-reiterates-full-year-guidance/ 2024-04-16T16:48:57Z https://www.hikma.com/news/hikma-appoints-douglas-hurt-as-director/ 2024-04-16T16:49:07Z https://www.hikma.com/news/hikma-ventures-invests-in-altoida-inc-a-predictive-digital-biomarker-company-using-ai-and-ar-to-help-predict-brain-diseases-with-up-to-94-accuracy/ 2024-02-12T16:27:27Z https://www.hikma.com/news/hikma-launches-nicardipine-hydrochloride-premixed-injection-in-ready-to-use-bags/ 2024-02-12T16:29:13Z https://www.hikma.com/news/hikma-launches-buprenorphine-hydrochloride-injection/ 2024-02-12T16:30:48Z https://www.hikma.com/news/hikma-launches-employee-matching-donation-campaign-to-support-local-us-food-banks-and-pantries/ 2024-04-16T16:50:54Z https://www.hikma.com/news/hikma-responds-to-covid-19-shortage-with-launch-of-propofol-injectable-emulsion-usp/ 2024-02-12T16:31:28Z https://www.hikma.com/news/hikma-launches-dicyclomine-hydrochloride-oral-solution/ 2024-02-12T16:32:14Z https://www.hikma.com/news/hikma-launches-a-generic-version-of-afinitor-tablets-25mg-5mg-75mg/ 2024-02-12T16:33:19Z https://www.hikma.com/news/hikma-and-sun-pharma-enter-into-exclusive-licensing-agreement-for-ilumya-for-the-middle-east-and-north-africa-region/ 2024-02-12T16:33:40Z https://www.hikma.com/news/hikma-announces-buy-back-of-up-to-approximately-295-million-of-shares-from-boehringer-ingelheim/ 2024-02-12T16:34:32Z https://www.hikma.com/news/transaction-in-own-shares-and-total-voting-rights-and-capital/ 2024-02-12T16:35:09Z https://www.hikma.com/news/hikma-successfully-completes-500-million-5-year-eurobond-issue/ 2024-04-16T16:52:36Z https://www.hikma.com/news/notice-of-results-3/ 2024-04-23T17:46:49Z https://www.hikma.com/news/hikma-launches-dacarbazine-for-injection-usp/ 2024-04-17T07:07:52Z https://www.hikma.com/news/hikma-improves-performance-in-ftse4good-index/ 2024-02-12T16:12:36Z https://www.hikma.com/news/hikma-delivers-strong-first-half-performance-and-raises-full-year-guidance/ 2024-04-17T07:08:21Z https://www.hikma.com/news/hikma-improves-its-performance-in-ftse4good-index/ 2024-04-17T07:08:28Z https://www.hikma.com/news/hikma-ventures-participates-in-cad40-million-series-a-financing-round-for-seamlessmd-to-expand-digital-patient-engagement-leadership/ 2024-02-12T16:35:54Z https://www.hikma.com/news/hikma-launches-azacitidine-for-injection/ 2024-04-17T07:08:48Z https://www.hikma.com/news/hikma-provides-update-on-status-of-anda-for-generic-advair-diskus/ 2024-04-17T07:09:17Z https://www.hikma.com/news/hikma-and-arecor-expand-collaboration-with-new-agreement-to-develop-and-commercialise-ready-to-administer-medicine/ 2024-02-12T16:36:42Z https://www.hikma.com/news/hikma-assigned-investment-grade-status-from-fitch-ratings/ 2024-04-17T07:09:56Z https://www.hikma.com/news/hikma-launches-rufinamide-oral-suspension-40-mgml/ 2024-02-12T16:37:39Z https://www.hikma.com/news/hikma-continues-strong-2020-performance-and-updates-full-year-guidance/ 2024-04-17T07:10:12Z https://www.hikma.com/news/hikma-launches-icosapent-ethyl-capsules/ 2024-04-17T07:10:22Z https://www.hikma.com/news/hikma-pharmaceuticals-and-sesen-bio-announce-exclusive-partnership-to-commercialise-vicineum-in-mena/ 2024-04-17T07:10:33Z https://www.hikma.com/news/hikma-launches-ropivacaine-hcl-injection-usp-for-anaesthesia-and-acute-pain-management/ 2024-04-17T07:10:45Z https://www.hikma.com/news/hikma-launches-generic-advair-diskus-following-fda-approval/ 2024-04-17T07:10:55Z https://www.hikma.com/news/hikma-announces-exclusive-agreement-with-sciecure-pharma-for-niche-injectable-anti-viral-medicine/ 2024-04-17T07:11:04Z https://www.hikma.com/news/hikma-to-present-at-37th-annual-jp-morgan-healthcare-conference/ 2024-04-17T07:11:16Z https://www.hikma.com/news/hikma-participates-in-2019-world-economic-forum-annual-meeting-in-davos-switzerland/ 2024-04-17T07:11:25Z https://www.hikma.com/news/hikma-launches-mitomycin-for-injection-usp/ 2024-04-17T07:16:14Z https://www.hikma.com/news/hikma-launches-abiraterone-acetate-tablets/ 2024-04-17T07:16:23Z https://www.hikma.com/news/notice-of-results-4/ 2024-04-17T07:16:40Z https://www.hikma.com/news/hikma-establishes-partnership-with-melinta-in-mena/ 2024-04-17T07:16:48Z https://www.hikma.com/news/hikma-board-appoints-cynthia-schwalm-as-director/ 2024-04-17T07:16:59Z https://www.hikma.com/news/hikma-delivers-strong-2018-results-and-makes-good-strategic-progress-to-position-for-future-growth/ 2024-02-12T16:38:07Z https://www.hikma.com/news/hikma-launches-norepinephrine-bitartrate-injection-usp/ 2024-04-17T07:17:34Z https://www.hikma.com/news/hikma-participates-in-world-economic-forum-on-the-middle-east-and-north-africa-at-dead-sea-jordan/ 2024-04-17T07:17:44Z https://www.hikma.com/news/hikma-launches-100th-injectable-medicine-in-us-with-introduction-of-vancomycin-hydrochloride-for-injection-usp/ 2024-04-17T07:17:57Z https://www.hikma.com/news/hikma-sponsors-mit-grand-hack-to-support-global-healthcare-innovation/ 2024-02-12T16:39:10Z https://www.hikma.com/news/hikma-announces-positive-start-to-2019-and-reiterates-guidance/ 2024-04-17T07:18:10Z https://www.hikma.com/news/hikma-ventures-participates-in-11-million-funding-round-for-pillo-health/ 2024-04-17T07:18:23Z https://www.hikma.com/news/hikma-launches-bosentan-tablets/ 2024-04-17T07:18:34Z https://www.hikma.com/news/notice-of-interim-results/ 2024-02-12T16:41:14Z https://www.hikma.com/news/hikma-and-civica-rx-sign-long-term-agreement-to-reduce-generic-drug-shortages-in-the-us/ 2024-04-17T07:18:55Z https://www.hikma.com/news/hikma-and-richter-sign-a-license-and-supply-agreement-for-cariprazine-in-mena/ 2024-04-17T07:19:04Z https://www.hikma.com/news/hikma-launches-cisplatin-injection/ 2024-04-17T07:19:14Z https://www.hikma.com/news/hikma-remains-constituent-of-the-ftse4good-index-series-for-5th-consecutive-year/ 2024-04-17T07:19:32Z https://www.hikma.com/news/hikma-appoints-dr-shahin-fesharaki-as-chief-scientific-officer-and-global-head-of-rd/ 2024-04-17T07:19:55Z https://www.hikma.com/news/hikma-delivers-strong-first-half-results-and-raises-full-year-guidance/ 2024-02-12T16:43:39Z https://www.hikma.com/news/hikma-acquisition-expands-nasal-spray-capabilities-and-pipeline/ 2024-02-12T16:44:50Z https://www.hikma.com/news/hikma-launches-phenylephrine-hydrochloride-injection-usp/ 2024-02-01T11:42:02Z https://www.hikma.com/news/hikma-launches-tetrabenazine-tablets/ 2024-04-17T07:20:25Z https://www.hikma.com/news/hikma-launches-prefilled-syringes-in-the-us/ 2024-04-17T07:20:34Z https://www.hikma.com/news/hikma-continues-strong-2019-performance-and-reiterates-full-year-guidance/ 2024-04-17T07:20:52Z https://www.hikma.com/news/hikma-ventures-leads-series-a-financing-for-development-of-winterlight-labs-ai-vocal-technology-to-detect-central-nervous-system-disorders-and-track-efficacy-of-treatments/ 2024-04-17T07:21:10Z https://www.hikma.com/news/hikma-completes-its-fda-response-for-generic-advair/ 2024-04-17T07:21:22Z https://www.hikma.com/news/hikma-receives-recognition-for-supporting-united-nations-sustainable-development-goals-for-the-second-consecutive-year/ 2024-04-17T07:21:31Z https://www.hikma.com/news/civica-rx-and-hikma-announce-shipments-of-heparin-and-seven-other-essential-injectable-medicines/ 2024-02-12T16:45:36Z https://www.hikma.com/news/hikma-and-arecor-announce-exclusive-agreement-to-develop-and-commercialise-ready-to-use-medicine-using-arestat-technology/ 2024-04-17T07:21:47Z https://www.hikma.com/news/hikma-licenses-chiesi-group-s-respiratory-and-neonatal-products-for-egyptian-market/ 2024-04-17T07:22:02Z https://www.hikma.com/news/hikma-joins-50th-world-economic-forum-annual-meeting-in-davos-switzerland/ 2024-04-17T07:22:12Z https://www.hikma.com/news/hikma-launches-ifosfamide-injection/ 2024-02-12T14:44:21Z https://www.hikma.com/news/hikma-pharmaceuticals-participates-in-world-economic-forum-in-switzerland/ 2024-02-12T14:44:22Z https://www.hikma.com/news/west-ward-pharmaceuticals-strengthens-us-leadership-and-appoints-daniel-motto-as-executive-vice-president-of-us-injectables/ 2024-04-17T07:22:32Z https://www.hikma.com/news/hikma-pharmaceuticals-participates-in-world-economic-forum-in-switzerland-marking-a-decade-of-its-involvement/ 2024-02-12T14:44:22Z https://www.hikma.com/news/sigurdur-olafsson-appointed-chief-executive-officer/ 2024-02-12T14:44:24Z https://www.hikma.com/news/notice-of-results-5/ 2024-02-12T14:44:25Z https://www.hikma.com/news/hikma-becomes-harvard-business-school-case-study-as-part-of-corporate-governance-and-making-boards-effective-modules/ 2024-02-01T12:28:54Z https://www.hikma.com/news/hikma-provides-an-update-on-the-status-of-its-anda-for-generic-advair-diskus/ 2024-02-12T14:44:25Z https://www.hikma.com/news/hikma-starts-rollout-of-new-global-brand/ 2024-04-17T07:23:17Z https://www.hikma.com/news/hikma-reports-2017-full-year-results/ 2024-02-01T12:29:56Z https://www.hikma.com/news/hikma-pharmaceuticals-becomes-patron-of-the-prince-s-trust-supporting-young-people-into-education-and-employment/ 2024-02-12T14:44:27Z https://www.hikma.com/news/hikma-has-launched-ritonavir-tablets-usp/ 2024-04-17T07:40:13Z https://www.hikma.com/news/hikma-launches-palonosetron-hydrochloride-injection/ 2024-04-17T07:40:25Z https://www.hikma.com/news/hikma-launches-epirubicin-hydrocholoride-injection-usp/ 2024-04-17T07:40:54Z https://www.hikma.com/news/hikma-launches-dexrazoxane-for-injection/ 2024-04-17T07:41:16Z https://www.hikma.com/news/princess-ghida-talal-opens-hikmas-annual-forum-for-the-treatment-of-leukemia-and-other-blood-cancers/ 2024-04-17T07:41:25Z https://www.hikma.com/news/hikma-expands-licensing-agreement-with-rovi-for-their-enoxaparin-biosimilar/ 2024-04-17T07:41:35Z https://www.hikma.com/news/hikma-launches-methotrexate-injection-usp-and-methotrexate-for-injection-usp/ 2024-04-17T07:41:43Z https://www.hikma.com/news/hikma-organizes-10th-annual-global-volunteering-campaign/ 2024-04-17T07:41:56Z https://www.hikma.com/news/hikma-launches-basilea-s-antibiotic-ceftobiprole-in-saudi-arabia/ 2024-04-17T07:42:07Z https://www.hikma.com/news/agm-trading-update/ 2024-04-17T07:42:21Z https://www.hikma.com/news/hikma-launches-methylergonovine-maleate-tablets-usp/ 2024-04-17T07:42:30Z https://www.hikma.com/news/hikma-appoints-henriette-nielsen-as-chief-transformation-officer/ 2024-04-17T07:42:43Z https://www.hikma.com/news/hikma-announces-the-close-of-the-roxane-laboratories-acquisition/ 2024-04-17T07:43:04Z https://www.hikma.com/news/west-ward-pharmaceuticals-now-hikma-in-the-us-as-part-of-global-rebranding/ 2024-04-17T10:30:36Z https://www.hikma.com/news/hikma-enters-into-licensing-partnership-with-perrigo-in-mena/ 2024-04-17T10:34:57Z https://www.hikma.com/news/hikma-launches-bleomycin-for-injection-usp/ 2024-04-17T10:35:20Z https://www.hikma.com/news/hikma-launches-daunorubicin-hcl-injection/ 2024-02-12T14:44:40Z https://www.hikma.com/news/save-the-date-investor-day-8-november-2018-1330/ 2024-02-12T14:44:42Z https://www.hikma.com/news/hikma-acts-to-ease-critical-shortage-of-pain-medications-needed-by-us-hospitals-and-their-patients/ 2024-04-17T10:36:13Z https://www.hikma.com/news/notice-of-results-august/ 2024-04-17T10:36:39Z https://www.hikma.com/news/hikma-launches-sterile-water-for-injection-usp/ 2024-04-17T10:37:07Z https://www.hikma.com/news/hikma-reports-strong-2018-interim-results-and-raises-full-year-guidance/ 2024-04-17T10:37:41Z https://www.hikma.com/news/hikma-pharmaceuticals-appoints-kristy-ronco-executive-vice-president-sales-and-marketing-generics/ 2024-04-17T10:37:58Z https://www.hikma.com/news/hikma-remains-constituent-of-ftse4good-index-series/ 2024-04-17T10:38:33Z https://www.hikma.com/news/hikma-launches-adriamycintm-doxorubicin-hcl-for-injection-usp/ 2024-04-17T10:38:47Z https://www.hikma.com/news/hikma-appoints-global-head-of-intellectual-property-and-us-general-counsel/ 2024-04-17T10:39:20Z https://www.hikma.com/news/hikma-ventures-participates-in-a-19-million-round-for-click-therapeutics/ 2024-04-17T10:39:33Z https://www.hikma.com/news/hikma-receives-recognition-for-supporting-united-nations-sustainable-development-goals/ 2024-04-17T10:40:10Z https://www.hikma.com/news/hikma-launches-imatinib-mesylate-tablets/ 2024-04-17T10:41:46Z https://www.hikma.com/news/reminder-investor-day-8-november-2018-1230pm-for-130pm/ 2024-04-17T10:41:30Z https://www.hikma.com/news/hikma-updates-on-current-trading-and-raises-2018-guidance/ 2024-04-17T10:42:05Z https://www.hikma.com/news/hikma-announces-global-agreement-with-vectura-to-develop-generic-versions-of-gsk-s-ellipta-portfolio/ 2024-04-17T10:42:22Z https://www.hikma.com/news/hikma-launches-triazolam-tablets/ 2024-04-17T10:43:04Z https://www.hikma.com/news/hikma-announces-exclusive-licensing-and-supply-agreement-with-hansoh-pharma-for-suite-of-injectable-oncology-medicines/ 2024-04-17T10:43:22Z https://www.hikma.com/news/hikma-demonstrates-support-for-us-pharmacists-and-patient-safety/ 2024-04-17T10:43:53Z https://www.hikma.com/news/hikma-launches-clobazam-oral-suspension-and-clobazam-tablets/ 2024-04-17T10:44:19Z https://www.hikma.com/news/hikma-launches-dalfampridine-extended-release-tablets/ 2024-04-17T10:44:39Z https://www.hikma.com/news/hikma-ventures-participates-in-a-205-million-series-c-round-for-prognos/ 2024-02-12T14:44:59Z https://www.hikma.com/news/hikma-ventures-invests-in-biolinq-the-next-generation-minimally-invasive-biosensor-technology-company/ 2024-04-17T11:14:20Z https://www.hikma.com/news/trading-update/ 2024-02-12T14:45:04Z https://www.hikma.com/news/hikma-wins-company-of-the-year-at-the-global-generics-biosimilars-awards-2017/ 2024-04-17T11:14:56Z https://www.hikma.com/news/hikma-pharmaceuticals-remains-constituent-of-ftse4good-sustainability-index/ 2024-04-17T11:15:13Z https://www.hikma.com/news/hikma-delivers-stable-profitability-and-strong-cash-generation-in-h1-and-maintains-a-solid-balance-sheet/ 2024-02-12T14:45:07Z https://www.hikma.com/news/notice-of-results-6/ 2024-04-17T11:15:46Z https://www.hikma.com/news/hikma-pharmaceuticals-announces-leadership-and-organisational-changes-to-us-business/ 2024-04-17T11:16:01Z https://www.hikma.com/news/hikma-ventures-co-leads-11-million-series-a-round-in-lemonaid-health/ 2024-02-01T12:37:05Z https://www.hikma.com/news/agm-trading-update-1/ 2024-02-12T14:45:11Z https://www.hikma.com/news/hikma-collaborates-with-the-department-of-leukemia-at-the-md-anderson-cancer-center/ 2024-02-01T12:37:23Z https://www.hikma.com/news/hikma-delivers-a-solid-financial-performance-in-2016-and-makes-significant-strategic-progress-strong-growth-in-revenue-and-core-operating-profit-in-constant-currency/ 2024-02-12T14:45:11Z https://www.hikma.com/news/hikma-pharmaceuticals-plc-hikma-will-announce-its-preliminary-financial-results-for-the-year-ended-31-december-2016-on-wednesday-15-march-2017/ 2024-02-12T14:45:13Z https://www.hikma.com/news/hikma-pharmaceuticals-participates-in-2017-world-economic-forum-in-jordan/ 2024-04-17T11:37:46Z https://www.hikma.com/news/hikma-pharmaceuticals-to-publish-report-on-its-alignment-with-un-sustainable-development-goals/ 2024-02-01T12:38:53Z https://www.hikma.com/news/hikma-pharmaceuticals-health-partner-of-the-world-economic-forum-in-davos/ 2024-02-12T14:45:15Z https://www.hikma.com/news/hikma-update-on-anda-for-generic-advair-diskus/ 2024-02-12T14:45:16Z https://www.hikma.com/news/hikma-receives-fda-approval-for-neostigmine-methylsulfate-injection/ 2024-02-12T14:45:18Z https://www.hikma.com/news/hikma-announces-revised-terms-for-previously-announced-acquisition-of-roxane-laboratories/ 2024-02-12T14:45:19Z https://www.hikma.com/news/notice-of-results-march-2016/ 2024-02-12T14:45:19Z https://www.hikma.com/news/hikma-pharmaceuticals-preliminary-results/ 2024-02-12T14:45:20Z https://www.hikma.com/news/hikma-s-anda-for-generic-advair-diskus-accepted-for-filing-by-fda/ 2024-02-12T14:45:21Z https://www.hikma.com/news/hikma-announces-fda-approval-and-launch-of-fluticasone-50-mcg-spray-the-store-brand-equivalent-of-flonase/ 2024-02-12T14:45:22Z https://www.hikma.com/news/hikma-acquires-six-injectable-products-in-europe/ 2024-02-01T12:39:55Z https://www.hikma.com/news/notice-of-results-august-2016/ 2024-02-12T14:45:23Z https://www.hikma.com/news/hikma-ventures-invests-in-chrono-therapeutics-for-the-development-of-next-generation-trans-dermal-drug-delivery-technology/ 2024-02-12T14:45:24Z https://www.hikma.com/news/board-appointment-and-succession/ 2024-02-12T14:45:26Z https://www.hikma.com/news/agm-trading-update-2/ 2024-02-12T14:45:27Z https://www.hikma.com/news/hikma-wins-mitigare-colchicine-patent-infringement-case/ 2024-02-01T12:40:38Z https://www.hikma.com/news/michael-raya-ceo-of-west-ward-pharmaceuticals-hikmas-wholly-owned-subsidiary-in-the-us-joins-gpha/ 2024-02-01T12:40:46Z https://www.hikma.com/news/hikma-delivers-solid-first-half-performance-and-reiterates-full-year-revenue-guidance-of-20-billion-to-21-billion/ 2024-02-12T14:45:29Z https://www.hikma.com/news/meet-the-management-day/ 2024-02-12T14:45:31Z https://www.hikma.com/news/said-darwazah-chairman-and-ceo-of-hikma-awarded-global-generics-leader-of-the-year/ 2024-02-12T14:45:33Z https://www.hikma.com/news/hikma-ventures-invests-in-propeller-health-for-the-enhancement-of-leading-respiratory-technology-platform/ 2024-05-20T15:18:29Z https://www.hikma.com/news/trading-update-november-2016/ 2024-02-12T14:45:35Z https://www.hikma.com/news/hikma-pharmaceuticals-launches-october-breast-cancer-awareness-campaign/ 2024-02-01T12:41:33Z https://www.hikma.com/news/hikma-pharmaceuticals-to-participate-in-the-world-economic-forums-industry-strategy-meeting/ 2024-02-01T11:49:40Z https://www.hikma.com/news/hikma-pharmaceuticals-celebrates-ninth-annual-global-volunteering-day/ 2024-02-01T11:49:45Z https://www.hikma.com/news/hikma-launches-cancer-awareness-campaign/ 2024-02-12T14:45:36Z https://www.hikma.com/news/hikma-partners-with-the-world-economic-forum/ 2024-02-12T14:45:36Z https://www.hikma.com/news/hikma-recieved-fda-approval-for-cyanocobalamin-injection/ 2024-02-12T14:45:37Z https://www.hikma.com/news/hikma-receives-fda-approval-for-azathioprine-sodium-injection/ 2024-02-12T14:45:38Z https://www.hikma.com/news/hikma-receives-fda-approval-for-rifampin-injection/ 2024-02-12T14:45:39Z https://www.hikma.com/news/hikma-receives-fda-approval-for-methylprednisolone-sodium-succinate-injection/ 2024-02-12T14:45:40Z https://www.hikma.com/news/hikma-receives-fda-approval-for-etomidate-injection/ 2024-02-12T14:45:40Z https://www.hikma.com/news/hikma-receives-fda-approval-for-acyclovir-injection/ 2024-02-12T14:45:41Z https://www.hikma.com/news/hikma-receives-fda-approval-for-temozolomide-capsules/ 2024-02-12T14:45:43Z https://www.hikma.com/news/hikma-s-anda-for-generic-advair-diskus-accepted-for-filing-by-fda-1/ 2024-02-12T14:45:44Z https://www.hikma.com/news/hikma-receives-fda-approval-for-leucovorin-calcium-injection/ 2024-02-12T14:45:45Z https://www.hikma.com/news/hikma-receives-fda-approval-for-fluphenazine-decanoate-injection/ 2024-02-12T14:45:46Z https://www.hikma.com/news/hikma-receives-drug-shortage-assistance-award-from-us-fda/ 2024-02-01T12:44:25Z https://www.hikma.com/news/hikma-receives-fda-approval-for-ketamine-hydrochloride-injection/ 2024-02-12T14:45:48Z https://www.hikma.com/news/hikma-announces-launch-of-generic-xeloda-tablets-150-mg-and-500-mg-in-the-us/ 2024-02-12T14:45:49Z https://www.hikma.com/news/regulatory-approval-of-hikma-s-colchicine-is-upheld/ 2024-02-12T14:45:50Z https://www.hikma.com/news/trading-update-1/ 2024-02-12T14:45:51Z https://www.hikma.com/news/trading-update-november-2015/ 2024-02-12T14:45:51Z https://www.hikma.com/news/hikma-awarded-best-company-in-an-emerging-market/ 2024-02-12T14:45:52Z https://www.hikma.com/news/hikma-launches-phentolamine-mesylate-injection-in-the-us/ 2024-02-12T14:45:53Z https://www.hikma.com/news/hikma-founder-and-honorary-life-president-samih-darwazah-passes-away/ 2024-04-17T11:49:53Z https://www.hikma.com/news/hikma-signs-exclusive-licensing-distribution-and-supply-agreement-with-basilea-pharmaceutica-international-ltd-for-zevtera/ 2024-02-12T14:45:55Z https://www.hikma.com/news/hikma-awarded-global-generics-acquisition-of-the-year/ 2024-02-12T14:45:56Z https://www.hikma.com/news/hikma-agrees-to-acquire-eimc-united-pharmaceuticals-strengthening-its-position-in-the-large-and-fast-growing-egyptian-market/ 2024-02-01T12:45:35Z https://www.hikma.com/news/hikma-enters-into-partnership-with-vitabiotics-for-the-promotion-and-distribution-of-vitabiotics-leading-healthcare-products-in-mena/ 2024-02-01T12:45:45Z https://www.hikma.com/news/hikma-pharmaceuticals-interim-results/ 2024-04-23T18:01:44Z https://www.hikma.com/news/notice-of-interim-results-announcement-analyst-presentation/ 2024-02-12T14:45:58Z https://www.hikma.com/news/hikma-acquires-roxane-laboratories-transforming-its-position-in-the-us-generics-market/ 2024-02-01T12:46:09Z https://www.hikma.com/news/hikma-appoints-kofi-amegashie-to-head-its-sub-saharan-africa-unit/ 2024-02-01T12:46:17Z https://www.hikma.com/news/hikma-agm-trading-update/ 2024-02-12T14:45:59Z https://www.hikma.com/news/notice-of-prelim-results-announcement-analyst-presentation/ 2024-02-12T14:45:59Z https://www.hikma.com/news/hikma-signs-exclusive-license-agreement-with-azanta-for-nimoral/ 2024-02-12T14:46:00Z https://www.hikma.com/news/hikma-pharmaceuticals-first-jordanian-site-to-receive-iso-50001-certification/ 2024-02-12T14:46:01Z https://www.hikma.com/news/hikma-to-launch-colchicine-06mg-capsules/ 2024-02-12T14:46:02Z https://www.hikma.com/news/hikma-renews-un-global-compact-membership/ 2024-02-12T14:46:02Z https://www.hikma.com/news/hikma-receives-high-score-in-cdp-global-climate-change-report-2015/ 2024-02-12T14:46:03Z https://www.hikma.com/news/hikma-pharmaceuticals-goes-pink-for-breast-cancer-awareness-month/ 2024-02-12T14:46:04Z https://www.hikma.com/news/hikma-renews-partnership-with-injaz-for-youth-programs/ 2024-02-12T14:46:05Z https://www.hikma.com/news/hikma-pharmaceuticals-supports-the-free-open-days-at-the-children-s-museum-jordan/ 2024-04-17T11:56:15Z https://www.hikma.com/news/hikma-pharmaceuticals-launches-ramadan-community-campaign/ 2024-04-17T11:56:44Z https://www.hikma.com/news/hikma-pharmaceuticals-holds-its-annual-global-volunteering-day/ 2024-04-17T11:57:33Z https://www.hikma.com/news/hikma-partners-against-corruption-and-supports-mena-growth-markets-at-wef/ 2024-02-01T11:52:34Z https://www.hikma.com/news/hikma-files-for-generic-zytiga-approval/ 2024-02-12T14:46:07Z https://www.hikma.com/news/hikma-receives-approval-for-thiotepa-injection-in-the-us/ 2024-02-01T11:52:42Z https://www.hikma.com/news/hikma-launches-caffeine-citrate-injection-commercialising-the-first-of-the-bedford-products/ 2024-02-12T14:46:08Z https://www.hikma.com/news/board-appointment-dr-pamela-kirby/ 2024-02-12T14:46:08Z https://www.hikma.com/news/interim-management-statement/ 2024-02-12T14:46:11Z https://www.hikma.com/news/hikma-meet-the-management-day-london/ 2024-02-12T14:46:11Z https://www.hikma.com/news/hikma-awarded-global-generics-company-of-the-year-for-emea/ 2024-02-01T11:53:03Z https://www.hikma.com/news/hikma-receives-approval-for-colchicine-06mg-capsules/ 2024-02-12T14:46:13Z https://www.hikma.com/news/hikma-meet-the-management-day/ 2024-02-12T14:46:14Z https://www.hikma.com/news/hikma-completes-acquisition-of-ben-venue-manufacturing-site/ 2024-02-12T14:46:15Z https://www.hikma.com/news/hikma-pharmaceuticals-interim-results-1/ 2024-02-12T14:46:16Z https://www.hikma.com/news/notice-of-interim-results-announcement-analyst-presentation-1/ 2024-02-12T14:46:17Z https://www.hikma.com/news/hikma-agrees-to-acquire-ben-venue-manufacturing-site-adding-rd-capabilities-and-capacity/ 2024-02-12T14:46:20Z https://www.hikma.com/news/hikma-completes-the-acquisition-of-assets-of-bedford-laboratories/ 2024-02-01T11:53:30Z https://www.hikma.com/news/hikma-pharmaceuticals-plc-acquisition-of-bedford-laboratories/ 2024-02-01T11:53:34Z https://www.hikma.com/news/interim-management-statement-may-2014/ 2024-02-12T14:46:21Z https://www.hikma.com/news/hikma-announces-successful-resolution-to-us-fda-warning-letter-at-eatontown-facility/ 2024-02-01T11:53:43Z https://www.hikma.com/news/notice-of-prelim-results-announcement-analyst-presentation-1/ 2024-02-12T14:46:22Z https://www.hikma.com/news/trading-update-2/ 2024-02-12T14:46:23Z https://www.hikma.com/news/board-changes/ 2024-02-12T14:46:23Z https://www.hikma.com/news/hikma-globalizes-its-pharmacovigilance-activities/ 2024-02-12T14:46:24Z https://www.hikma.com/news/hikma-pharmaceuticals-launches-you-are-hikma-2014-campaign/ 2024-02-12T14:46:25Z https://www.hikma.com/news/hikma-holds-its-7th-volunteering-day/ 2024-02-12T14:46:26Z https://www.hikma.com/news/hikma-pharmaceuticals-supports-and-takes-part-in-earth-hour-2014/ 2024-02-12T14:46:28Z https://www.hikma.com/news/hikma-enters-partnership-with-eisai-for-distribution-of-first-in-class-epilepsy-treatment-fycompa-in-middle-east/ 2024-02-01T11:54:11Z https://www.hikma.com/news/hikma-and-aub-collaborate-on-developing-anticancer-treatment-from-medicinal-plants/ 2024-02-01T11:54:15Z https://www.hikma.com/news/hikma-signs-license-and-supply-agreement-with-sk-chemicals-for-its-rivastigmine-transdermal-patch/ 2024-02-12T14:46:29Z https://www.hikma.com/news/samih-darwazah-tops-scrip-emerging-markets-leaders/ 2024-02-12T14:46:30Z https://www.hikma.com/news/hikma-signs-long-term-supply-agreement-with-unilife-to-enhance-delivery-of-generic-injectables/ 2024-02-12T14:46:32Z https://www.hikma.com/news/interim-management-statement-1/ 2024-02-12T14:46:32Z https://www.hikma.com/news/hikma-signs-additional-license-and-supply-agreement-with-gp-pharm-for-its-leading-oncology-compound-for-germany-and-portugal/ 2024-02-01T11:54:35Z https://www.hikma.com/news/hikma-entering-ethiopian-pharmaceutical-market-through-a-joint-venture-with-midroc-group/ 2024-02-12T14:46:34Z https://www.hikma.com/news/hikma-pharmaceuticals-interim-results-2/ 2024-02-12T14:46:34Z https://www.hikma.com/news/notice-of-interim-results-announcement-analyst-presentation-2/ 2024-02-12T14:46:35Z https://www.hikma.com/news/hikma-upgrades-2013-group-revenue-guidance/ 2024-02-12T14:46:36Z https://www.hikma.com/news/agm-and-interim-management-statement/ 2024-02-12T14:46:38Z https://www.hikma.com/news/hikma-pharmaceuticals-strongly-objects-to-the-use-of-its-products-in-capital-punishment/ 2024-02-12T14:46:40Z https://www.hikma.com/news/hikma-signs-licensing-and-marketing-agreement-for-dance-biopharm-s-inhaled-insulin-in-mena/ 2024-02-01T11:55:03Z https://www.hikma.com/news/hikma-provides-update-on-its-global-injectables-business/ 2024-02-12T14:46:41Z https://www.hikma.com/news/hikma-pharmaceuticals-preliminary-results-1/ 2024-02-12T14:46:42Z https://www.hikma.com/news/notice-of-prelim-results-announcement-analyst-presentation-2/ 2024-02-12T14:46:43Z https://www.hikma.com/news/hikma-agrees-to-acquire-the-egyptian-company-for-pharmaceuticals-chemical-industries-strengthening-its-position-in-the-large-and-fast-growing-egyptian-market/ 2024-02-01T11:55:17Z https://www.hikma.com/news/hikma-to-present-at-the-31st-annual-jp-morgan-healthcare-conference/ 2024-02-12T14:46:44Z https://www.hikma.com/news/hikma-pharmaceuticals-for-investing-in-healthcare-at-the-world-economic-forum-dead-sea-2013/ 2024-04-23T18:05:39Z https://www.hikma.com/news/hikma-pharmaceuticals-enhances-employees-performance-through-training-sessions-and-workshops/ 2024-02-12T14:46:45Z https://www.hikma.com/news/hikma-pharmaceuticals-launches-its-global-volunteering-campaign-with-injaz-s-young-volunteer-day/ 2024-02-01T11:55:34Z https://www.hikma.com/news/hikma-pharmaceuticals-invites-top-organizations-to-towards-a-smoke-free-environment-session/ 2024-02-12T14:46:46Z https://www.hikma.com/news/hikma-licenses-vibativ-from-theravance/ 2024-02-12T14:46:47Z https://www.hikma.com/news/hikma-signs-agreement-with-sinclair-is-pharma-to-license-flammacerium-for-the-mena-region/ 2024-02-12T14:46:49Z https://www.hikma.com/news/hikma-signs-a-licensing-and-distribution-agreement-with-effrx-for-its-innovative-osteoporosis-medication/ 2024-02-12T14:46:51Z https://www.hikma.com/news/hikma-receives-approval-for-phenylephrine-hcl-injection-usp/ 2024-02-12T14:46:53Z https://www.hikma.com/news/interim-management-statement-2/ 2024-02-12T14:46:55Z https://www.hikma.com/news/hikma-pharmaceuticals-receives-ifc-client-leadership-award/ 2024-02-12T14:46:57Z https://www.hikma.com/news/hikma-injectables-analyst-and-investor-day/ 2024-02-12T14:46:58Z https://www.hikma.com/news/notice-hikma-injectables-analyst-and-investor-day-us/ 2024-02-12T14:47:00Z https://www.hikma.com/news/hikma-pharmaceuticals-interim-results-3/ 2024-04-17T12:08:31Z https://www.hikma.com/news/notice-of-interim-results-announcement-2012-analyst-presentation/ 2024-02-12T14:47:05Z https://www.hikma.com/news/agm-and-interim-management-statement-1/ 2024-02-12T14:47:06Z https://www.hikma.com/news/hikma-pharmaceuticals-preliminary-results-2/ 2024-02-12T14:47:06Z https://www.hikma.com/news/notice-for-preliminary-results-2011/ 2024-02-12T14:47:07Z https://www.hikma.com/news/hikma-holds-its-annual-training-workshops-for-human-resources-and-corporate-responsibility-employees/ 2024-02-12T14:47:08Z https://www.hikma.com/news/hikma-pharmaceuticals-stages-you-are-hikma-annual-employee-welfare-week/ 2024-02-12T14:47:09Z https://www.hikma.com/news/hikma-participates-in-csr-conference-at-american-university-of-beirut/ 2024-02-01T11:56:33Z https://www.hikma.com/news/hikma-pharmaceuticals-supports-national-strategy-to-combat-chronic-diseases/ 2024-02-12T14:47:09Z https://www.hikma.com/news/hikma-pharmaceuticals-celebrates-its-global-volunteering-day/ 2024-04-17T12:11:26Z https://www.hikma.com/news/hikma-pharmaceuticals-joins-efforts-with-king-abdullah-ii-center-for-excellence-and-king-hussein-cancer-center-to-create-smoke-free-environments/ 2024-04-17T12:11:39Z https://www.hikma.com/news/hikma-launches-argatroban-injection/ 2024-02-12T14:47:12Z https://www.hikma.com/news/hikma-signs-license-and-supply-agreement-with-gp-pharm-for-its-leading-oncology-compound/ 2024-02-12T14:47:15Z https://www.hikma.com/news/hikma-pharmaceuticals-partners-with-ergomed-for-clinical-trials-of-anti-cancer-medication/ 2024-02-12T14:47:16Z https://www.hikma.com/news/hikma-receives-approval-of-its-nda-for-argatroban-injection-100mgml-vial/ 2024-02-12T14:47:17Z https://www.hikma.com/news/hikma-pharmaceuticals-supports-paces-initiative/ 2024-02-09T17:32:03Z https://www.hikma.com/news/hikma-launches-therapeutic-heparin-in-the-us-market/ 2024-02-01T11:57:07Z https://www.hikma.com/news/hikma-in-licenses-major-proprietary-injectable-product-ferinject-for-the-mena-region/ 2024-02-01T11:57:12Z https://www.hikma.com/news/hikma-holds-global-volunteering-day-for-the-4th-consecutive-year/ 2024-02-09T17:31:45Z https://www.hikma.com/news/hikma-pharmaceuticals-signs-agreement-to-develop-an-industrial-pharmaceuticals-faculty/ 2024-02-09T17:31:30Z https://www.hikma.com/news/samih-darwazah-center-for-innovation-management-and-entrepreneurship-launched-at-american-university-of-beirut/ 2024-02-09T17:30:45Z https://www.hikma.com/news/pioneering-study-reveals-7-out-of-10-heart-attack-patients-have-diabetes/ 2024-04-17T12:13:18Z https://www.hikma.com/news/hikma-receives-fda-approval-for-cancer-drug-irinotecan/ 2024-02-09T17:27:57Z https://www.hikma.com/news/hikma-introduces-respirox-to-the-tunisian-market/ 2024-02-01T11:57:35Z https://www.hikma.com/news/new-anti-infective-products-launched/ 2024-02-09T17:21:22Z https://www.hikma.com/news/hikma-ceo-speaks-at-harvard-school-of-public-health-s-mena-conference/ 2024-02-01T11:57:45Z https://www.hikma.com/news/hikma-pharmaceuticals-holds-diabetes-awareness-campaign/ 2024-02-09T17:28:10Z https://www.hikma.com/news/hikma-pharmaceuticals-holds-anti-obesity-campaign/ 2024-02-09T17:26:02Z https://www.hikma.com/news/hikma-pharmaceuticals-holds-breast-cancer-awareness-campaign/ 2024-02-09T17:28:25Z https://www.hikma.com/news/hikma-pharmaceuticals-and-the-children-s-museum-jordan-enter-a-new-partnership/ 2024-02-09T17:25:39Z https://www.hikma.com/news/you-are-hikma-campaign/ 2024-02-09T17:22:14Z https://www.hikma.com/news/hikma-raises-awareness-for-breast-cancer-from-saudi-arabia-to-the-united-states/ 2024-02-09T17:18:48Z https://www.hikma.com/news/hikma-engages-with-its-communities-on-world-diabetes-day-2009/ 2024-02-09T16:55:42Z https://www.hikma.com/news/hikma-and-winterlight-labs-collaborate-to-develop-biomarkers-for-schizophrenia-patients-in-mena/ 2024-04-18T11:46:10Z https://www.hikma.com/news/hikma-announces-global-partnership-with-direct-relief/ 2024-04-18T11:46:26Z https://player.vimeo.com/external/260090344.hd.mp4?s=12973a35b9aaf5aa9e8b8e23a0e1705ac7bcaec7&profile_id=174 Video Video https://player.vimeo.com/external/260090344.hd.mp4?s=12973a35b9aaf5aa9e8b8e23a0e1705ac7bcaec7&profile_id=174 https://www.hikma.com/news/hikma-to-present-at-42nd-annual-jp-morgan-healthcare-conference/ 2024-02-12T12:19:51Z https://www.hikma.com/news/activ-surgical-a-hikma-ventures-portfolio-company-completes-the-first-international-procedure-using-activsight-intelligent-light-at-abdali-hospital-in-jordan/ 2024-02-09T15:49:58Z https://www.hikma.com/news/hikma-appoints-julie-hill-as-senior-vice-president-corporate-quality-compliancehealth-and-safety/ 2024-12-16T09:37:32Z https://www.hikma.com/news/notice-of-preliminary-results-2024/ 2024-02-20T09:50:39Z https://www.hikma.com/news/hikma-announces-agreement-in-principle-for-nationwide-us-opioid-settlement-framework/ 2024-02-16T09:50:37Z https://www.hikma.com/news/hikma-announces-us-launch-of-combogesic-iv/ 2024-02-20T09:50:40Z https://www.hikma.com/news/hikma-delivers-strong-h1-performance-and-raises-generics-guidance/ 2024-02-12T18:00:13Z https://www.hikma.com/news/hikma-ventures-invests-in-octave-bioscience-a-precision-care-platform-for-multiple-sclerosis-and-other-neurodegenerative-diseases/ 2024-02-12T18:02:22Z https://www.hikma.com/news/hikma-and-sk-biopharmaceuticals-enter-a-strategic-partnership-for-the-middle-east-and-north-africa/ 2024-02-12T17:51:23Z https://www.hikma.com/news/hikma-remains-a-constituent-of-the-ftse4good-index/ 2024-09-25T10:35:51Z https://www.hikma.com/news/hikma-launches-vancomycin-hydrochloride-for-injection-usp-in-the-us/ 2024-02-12T17:55:57Z https://www.hikma.com/news/hikma-launches-generic-version-of-vyvanse-following-fda-approval/ 2024-02-12T17:50:18Z https://www.hikma.com/news/hikma-marks-two-year-anniversary-of-kloxxado-launch-by-surpassing-375-000-doses-donated-in-the-us/ 2024-02-12T17:45:55Z https://www.hikma.com/news/hikma-and-cosmo-partner-on-exclusive-licensing-agreement-for-winlevi-clascoterone-for-the-middle-east-and-north-africa/ 2024-02-12T17:47:25Z https://www.hikma.com/news/hikma-launches-levocarnitine-injection-usp-in-the-us/ 2024-02-12T17:43:47Z https://www.hikma.com/news/hikma-and-canariabio-sign-exclusive-licensing-agreement-to-bring-oregovomab-to-the-middle-east-and-north-africa/ 2024-02-12T17:43:04Z https://www.hikma.com/news/hikma-launches-phenylephrine-hcl-injection-usp-in-ready-to-use-vials-in-the-us/ 2024-02-12T17:44:20Z https://www.hikma.com/news/hikma-continues-strong-momentum-across-the-group-and-upgrades-guidance-for-2023/ 2024-02-12T17:54:59Z https://www.hikma.com/news/company-secretary-change/ 2024-02-12T17:54:30Z https://www.hikma.com/news/hikma-launches-alvimopan-capsules-in-the-us/ 2024-02-28T08:40:34Z https://www.hikma.com/news/hikma-launches-fentanyl-citrate-injection-usp-in-a-prefilled-syringe-in-the-us/ 2024-03-06T12:31:10Z https://www.hikma.com/news/hikma-hosts-white-house-drug-policy-director-dr-rahul-gupta-at-its-columbus-ohio-manufacturing-facility/ 2024-03-07T17:05:15Z https://www.hikma.com/news/hikma-delivers-strong-2023-performance-and-a-positive-outlook-for-2024/ 2024-02-22T07:02:02Z https://www.hikma.com/news/hikma-s-executive-vice-chairman-and-president-of-mena-joins-rakuten-medical-s-board-of-directors/ 2024-12-16T09:41:19Z https://www.hikma.com/news/hikma-appoints-dr-hafrun-fridriksdottir-as-president-of-generics-business/ 2024-12-16T09:36:19Z https://www.hikma.com/news/hikma-has-strong-start-to-2024-with-continued-momentum-across-all-businesses-full-year-guidance-reiterated/ 2024-04-25T06:01:45Z https://www.hikma.com/news/bringing-better-health-within-reach-hikma-s-journey-to-become-the-partner-of-choice-in-mena/ 2024-11-16T05:23:40Z https://www.hikma.com/news/hikma-launches-midazolam-injection-usp-in-a-prefilled-syringe-in-the-us/ 2024-05-23T16:22:47Z https://www.hikma.com/news/hikma-enters-the-spanish-generic-injectables-market-strengthening-its-european-presence/ 2024-06-04T04:37:46Z https://www.hikma.com/news/hikma-opens-new-uk-office-to-support-nhs-supply-strengthening-european-presence/ 2024-06-18T05:24:06Z https://www.hikma.com/news/hikma-pharmaceuticals-reaffirms-commitment-to-expanding-access-to-overdose-reversal-medicine-naloxone-at-white-house-meeting/ 2024-06-21T08:31:22Z https://www.hikma.com/news/hikma-acquires-xellia-s-differentiated-portfolio-and-enhances-injectables-pipeline-manufacturing-capabilities-and-rd/ 2024-07-02T00:28:19Z https://www.hikma.com/news/hikma-a-legacy-of-quality-for-a-better-future/ 2025-01-11T12:09:20Z https://www.hikma.com/news/hikma-launches-sodium-acetate-injection-usp-in-the-us/ 2024-07-11T08:02:09Z https://www.hikma.com/news/notice-of-results-7/ 2024-07-15T06:00:47Z https://www.hikma.com/news/hikma-pharmaceuticals-receives-permanent-j-code-for-combogesic-iv-acetaminophen-and-ibuprofen-injection-from-centers-for-medicare-medicaid-services-cms/ 2025-02-02T04:12:04Z https://www.hikma.com/news/hikma-pharmaceuticals-usa-inc-extends-voluntary-nationwide-recall-of-one-lot-of-acetaminophen-injection/ 2025-02-08T19:13:54Z https://www.hikma.com/news/hikma-pharmaceuticals-how-our-three-businesses-work-together-to-improve-health/ 2025-06-26T10:13:09Z https://www.hikma.com/news/hikma-delivers-strong-h1-performance-and-upgrades-group-guidance/ 2024-08-08T06:13:07Z https://www.hikma.com/news/kloxxado-8mg-naloxone-nasal-spray-shelf-life-extended-from-24-months-to-36-months/ 2025-03-04T00:10:26Z https://www.hikma.com/news/hikma-pharmaceuticals-participates-in-naloxone-training-event-with-us-congressman-buddy-carter-ahead-of-national-fentanyl-awareness-and-prevention-day/ 2025-03-09T02:55:25Z https://www.hikma.com/news/bringing-better-health-within-reach-improving-access-to-medicine-as-the-partner-of-choice-in-mena/ 2025-03-17T02:55:37Z https://www.hikma.com/news/hikma-launches-clindamycin-in-5-dextrose-injection-in-the-us/ 2024-09-03T08:07:15Z https://www.hikma.com/news/hikma-completes-xellia-acquisition/ 2024-09-10T06:00:41Z https://www.hikma.com/news/hikma-launches-foscarnet-sodium-injection-in-the-us/ 2025-04-12T02:32:34Z https://www.hikma.com/news/hikma-celebrates-40-years-of-hatch-waxman-drug-savings/ 2025-04-19T11:21:26Z https://www.hikma.com/news/empowering-lives-hikma-s-regional-blood-donation-drives-across-mena/ 2024-10-21T10:13:32Z https://www.hikma.com/news/hikmas-leadership-receives-prestigious-recognitions-in-2024/ 2025-05-11T09:09:23Z https://www.hikma.com/news/hikma-continues-strong-strategic-execution-and-reiterates-guidance/ 2025-05-27T01:37:58Z https://www.hikma.com/news/celebrating-global-biosimilars-week-hikma-champions-access-to-essential-medicines-for-patients-in-the-mena-region/ 2025-06-01T01:38:19Z https://www.hikma.com/news/sell-side-analysts-and-investors-visit-hikma-casablanca-site/ 2024-11-14T08:01:30Z https://www.hikma.com/news/hikma-launches-furosemide-injection-in-the-us/ 2025-06-28T02:30:03Z https://www.hikma.com/news/hikma-and-richter-announce-fda-submission-acceptance-for-denosumab-biosimilar-products/ 2025-07-01T02:30:13Z https://www.hikma.com/news/hikma-acquires-the-rights-to-a-portfolio-of-takeda-brands-for-the-mena-region/ 2025-07-08T15:36:37Z https://www.hikma.com/news/hikma-launches-indomethacin-suppositories-in-the-us/ 2024-12-20T08:00:10Z https://www.hikma.com/news/hikma-receives-fda-approval-and-launches-the-generic-version-of-victoza-liraglutide-in-the-us/ 2025-07-15T15:37:00Z https://www.hikma.com/news/hikma-launches-ephedrine-sulfate-injection-usp-in-the-us/ 2024-12-30T09:01:44Z https://www.hikma.com/news/hikma-to-present-at-43rd-annual-jp-morgan-healthcare-conference/ 2025-01-13T12:03:17Z https://www.hikma.com/news/hikma-announces-exclusive-commercial-partnership-with-emergent-biosolutions-for-kloxxado-naloxone-hcl-nasal-spray-8-mg/ 2025-01-14T12:31:16Z https://www.hikma.com/news/hikma-launches-meropenem-for-injection-usp-in-the-us/ 2025-01-14T09:02:24Z https://www.hikma.com/news/hikma-and-m42-sign-strategic-mou-to-advance-healthcare-innovation-in-the-uae/ 2025-01-30T07:43:33Z https://www.hikma.com/news/notice-of-results-2024-full-year/ 2025-02-10T08:10:34Z https://www.hikma.com/news/strong-2024-performance-and-a-positive-outlook-for-2025/ 2025-09-15T14:18:09Z https://www.hikma.com/news/hikma-receives-fda-approval-and-launches-mercaptopurine-oral-suspension-in-the-us/ 2025-09-16T14:18:12Z https://www.hikma.com/news/hikma-to-host-meet-the-management-and-site-visit-in-columbus-ohio/ 2025-03-17T11:43:38Z https://www.hikma.com/news/shaping-a-healthier-world-by-developing-our-pipeline-in-growing-therapeutic-areas/ 2025-10-06T06:06:45Z https://www.hikma.com/news/shaping-a-healthier-world-by-focusing-on-our-quality-manufacturing/ 2025-10-06T06:06:45Z https://www.hikma.com/news/shaping-a-healthier-world-by-expanding-our-patient-reach-across-our-markets/ 2025-10-06T06:06:45Z https://www.hikma.com/news/shaping-a-healthier-world-by-investing-for-the-future/ 2025-10-06T06:06:46Z https://www.hikma.com/news/shaping-a-healthier-world-by-leveraging-our-role-as-a-leading-healthcare-provider-in-mena/ 2025-10-06T06:06:46Z https://www.hikma.com/news/providing-access-to-clean-water-for-families-in-egypt/ 2025-03-19T11:04:17Z https://www.hikma.com/news/supporting-food-banks-for-those-in-need/ 2025-03-19T11:01:45Z https://www.hikma.com/news/supporting-education-with-unhcr/ 2025-03-19T11:01:23Z https://www.hikma.com/news/hikma-announces-health-canada-approval-of-kloxxado-naloxone-hcl-nasal-spray-8-mg/ 2025-10-07T06:06:46Z https://www.hikma.com/news/hikma-launches-cisatracurium-besylate-injection-usp-in-the-us/ 2025-10-12T06:06:47Z https://www.hikma.com/news/hikma-where-our-purpose-inspires-our-people/ 2025-03-27T11:11:32Z https://www.hikma.com/news/hikma-signs-exclusive-licensing-agreement-with-pharma-to-bring-innovative-oncology-treatment-to-mena/ 2025-04-09T07:46:27Z https://www.hikma.com/news/inspiring-women-of-hikma-meet-nesrine-nouhi-general-manager-of-hikma-france/ 2025-04-17T10:50:46Z https://www.hikma.com/news/hikma-acquires-novugen-s-fda-approved-anda-for-trametinib/ 2025-04-17T15:00:33Z https://www.hikma.com/news/hikma-reiterates-full-year-guidance-following-good-start-to-the-year/ 2025-04-24T06:09:02Z https://www.hikma.com/news/hikma-announces-settlement-agreement-for-xyrem-sodium-oxybate-us-class-action-lawsuits/ 2025-11-25T02:38:22Z https://www.hikma.com/news/sp-upgrades-hikma-pharmaceuticals-plc-and-its-senior-notes-to-bbb-on-continued-good-business-momentum-outlook-stable/ 2025-05-08T09:49:47Z https://www.hikma.com/news/hikma-announces-strong-medium-term-group-guidance-ahead-of-its-us-site-visit/ 2025-12-02T02:38:43Z https://www.hikma.com/news/bio-thera-solutions-and-hikma-pharmaceuticals-announce-fda-approval-of-starjemza-ustekinumab-hmny-injection-a-biosimilar-referencing-stelara-ustekinumab-injection/ 2025-05-27T06:04:07Z https://www.hikma.com/news/inspiring-women-of-hikma-meet-stephanie-haas-senior-director-head-of-hikma-rx-procurement/ 2025-12-23T17:02:59Z https://www.hikma.com/news/hikma-launches-triamcinolone-acetonide-injectable-suspension-usp-in-the-us/ 2025-06-05T08:00:35Z https://www.hikma.com/news/fitch-upgrades-hikma-pharmaceuticals-plc-s-long-term-issuer-default-rating-to-bbb-outlook-stable/ 2025-05-29T06:01:58Z https://www.hikma.com/news/meet-ashanti-finley-specialist-in-the-people-function-team-at-berkeley-heights-us/ 2025-12-24T17:03:02Z https://www.hikma.com/news/meet-rawand-batarseh-sr-brand-manager-injectables-mena/ 2025-09-05T14:18:07Z https://www.hikma.com/news/meet-nawras-a-bnyyassien-health-safety-and-environment-manager-for-hikma-chemical-and-hikma-jordan/ 2025-06-30T12:37:03Z https://www.hikma.com/news/meet-mariam-mukarker-manager-quality-mena/ 2025-06-18T14:33:10Z https://www.hikma.com/news/meet-malek-saleem-finance-manager-injectables-mena/ 2025-06-30T12:40:11Z https://www.hikma.com/news/meet-maya-beano-pipeline-selection-manager-injectables-mena/ 2025-06-30T12:40:39Z https://www.hikma.com/news/meet-jamie-medina-manufacturing-inventory-control-supervisor-in-the-us/ 2025-06-30T12:41:00Z https://www.hikma.com/news/meet-nika-beck-manufacturing-specialist-at-hikma-503b-in-the-us/ 2025-06-30T12:42:28Z https://www.hikma.com/news/meet-majda-lhoufati-plant-manager-in-morocco/ 2025-06-18T15:07:12Z https://www.hikma.com/news/hikma-launches-methylene-blue-injection-usp-in-the-us/ 2026-01-12T14:50:12Z https://www.hikma.com/news/meet-nika-beck-and-learn-more-about-how-she-champions-quality/ 2025-07-29T02:26:32Z https://www.hikma.com/news/meet-osama-alrifai-and-learn-more-about-how-he-champions-quality/ 2025-07-10T15:36:43Z https://www.hikma.com/news/meet-lisa-hurley-and-learn-more-about-how-she-champions-quality/ 2025-07-10T15:36:43Z https://www.hikma.com/news/keeping-patients-safe-is-at-the-heart-of-everything-we-do/ 2025-09-19T14:18:13Z https://www.hikma.com/news/shaping-a-healthier-world-our-breast-cancer-awareness-campaigns/ 2025-07-10T15:36:44Z https://www.hikma.com/news/fostering-connection-and-compassion-hikma-s-community-dinner-in-portugal/ 2025-07-10T15:36:44Z https://www.hikma.com/news/hikma-joins-forces-with-the-jordan-hashemite-charity-organisation-to-establish-and-operate-the-charity-clothes-bank/ 2025-07-10T15:36:44Z https://www.hikma.com/news/inspiring-creativity-empowering-youth-transforming-the-art-studio-at-camp-oty-okwa/ 2025-07-10T15:36:44Z https://www.hikma.com/news/hikma-s-cherry-hill-site-wins-governor-s-environmental-excellence-award-in-the-us/ 2025-07-10T15:36:45Z https://www.hikma.com/news/expanding-our-onsite-renewable-energy-generation/ 2025-07-10T15:36:45Z https://www.hikma.com/news/inspiring-women-of-hikma-meet-judy-bock-associate-director-quality-assurance/ 2026-01-14T08:06:43Z https://www.hikma.com/news/hikma-pharmaceuticals-usa-announces-1-billion-of-new-us-investment-to-further-expand-its-domestic-manufacturing-and-development-of-essential-generic-medicines/ 2025-06-28T15:00:18Z https://www.hikma.com/news/hikma-publishes-its-2024-sustainability-report-reinforcing-commitment-to-global-access-to-medicines/ 2026-01-17T14:11:24Z https://www.hikma.com/news/hikma-rd-analytical-research-innovation-meet-samuel-cook/ 2026-01-17T14:11:25Z https://www.hikma.com/news/meet-farah-alasali-senior-officer-in-our-social-responsibility-team-based-in-jordan-hear-what-she-has-to-say-about-life-at-hikma-ownyourcareer/ 2025-07-02T13:44:09Z https://www.hikma.com/news/hikma-receives-fda-approval-for-tyzavan-vancomycin-injection-usp-in-the-us/ 2026-01-19T14:19:45Z https://www.hikma.com/news/supporting-communities-globally-highlights-from-our-2025-global-volunteer-campaign/ 2025-07-03T08:55:34Z https://www.hikma.com/news/notice-of-results-8/ 2025-07-09T08:03:04Z https://www.hikma.com/news/hikma-launches-morphine-sulfate-injection-usp-in-a-prefilled-syringe-in-the-us/ 2025-07-14T08:02:51Z https://www.hikma.com/news/hikma-remains-a-constituent-of-the-ftse4good-index-2025/ 2025-07-16T06:02:14Z https://www.hikma.com/news/hikma-rd-innovating-analytical-research-meet-saras-konar/ 2026-02-03T11:08:35Z https://www.hikma.com/news/hikma-rd-innovating-analytical-research-meet-raghad-saleh/ 2026-02-14T01:21:40Z https://www.hikma.com/news/hikma-delivers-a-solid-h1-performance-and-re-affirms-expectations-for-strong-growth-in-the-second-half/ 2026-02-24T11:05:15Z https://www.hikma.com/news/hikma-rd-innovating-clinical-research-meet-rand-alsaber/ 2026-03-02T02:04:39Z https://www.hikma.com/news/strategic-insights-into-hikma-injectables-cmo-meeting-partner-expectations/ 2026-03-03T02:04:43Z https://www.hikma.com/news/inspiring-women-of-hikma-meet-dr-nina-diaz-general-manager-of-hikma-thymoorgan-germany/ 2026-03-11T15:30:20Z https://www.hikma.com/news/acting-responsibly-for-purpose-driven-impact-how-hikma-champions-inclusive-education/ 2026-03-14T15:30:30Z https://www.hikma.com/news/hikma-rd-formulation-development-innovation-meet-mihir-modh/ 2026-03-15T15:30:35Z https://www.hikma.com/news/hikma-rd-analytical-research-innovation-meet-seham-samawi/ 2026-03-23T02:17:33Z https://www.hikma.com/news/hikma-rd-formulation-development-innovation-meet-timothy-owen/ 2025-09-15T12:13:39Z https://www.hikma.com/news/meet-jaclyn-bachman-associate-director-validations-metrology-cherry-hill-us-injectables-division/ 2025-09-16T08:44:09Z https://www.hikma.com/news/hikma-and-richter-receive-fda-approval-for-denosumab-biosimilars-enobytm-denosumab-qbde-and-xtrenbotm-denosumab-qbde-referencing-prolia-and-xgeva-respectively/ 2025-09-29T09:00:56Z https://www.hikma.com/news/hikma-rd-innovating-formulation-development-meet-helena-sremec/ 2025-09-29T07:03:48Z https://youtu.be/9kFN86hrvCQ Video Video https://youtu.be/9kFN86hrvCQ https://www.hikma.com/news/hikma-and-celltrion-strengthen-partnership-to-expand-biosimilar-access-in-mena/ 2025-10-06T06:00:15Z https://www.hikma.com/news/driving-pharmaceutical-excellence-and-growth-in-pavia-a-qa-with-roberto-gagliano-general-manager-hikma-italia/ 2025-10-03T15:05:17Z https://www.hikma.com/news/inspiring-women-of-hikma-meet-christine-schneider-general-manager-hikma-germany/ 2025-10-15T09:58:32Z https://www.hikma.com/news/hikma-rd-innovating-formulation-development-meet-anas-younues/ 2025-10-15T11:08:15Z https://www.hikma.com/news/hikma-rd-innovating-analytical-development-meet-edvin-brusac/ 2025-10-23T13:08:05Z https://www.hikma.com/news/hikma-confirms-2025-guidance-and-updates-medium-term-growth-outlook/ 2025-11-06T07:56:41Z https://www.hikma.com/news/hikma-rd-innovating-formulation-development-meet-razan-alsawwaf/ 2025-11-10T11:32:44Z https://www.hikma.com/news/hikma-pharmaceuticals-announces-the-launch-of-starjemza-ustekinumab-hmny-injection-a-biosimilar-referencing-stelara-ustekinumab-injection/ 2025-11-06T06:55:22Z https://www.hikma.com/news/strategic-priorities-in-hikma-pharmaceuticals-rd-qa-with-hafrun-fridriksdottir-president-rx-and-rd/ 2025-12-04T13:16:31Z https://www.hikma.com/news/hikma-signs-an-exclusive-agreement-with-dgi-group-to-bring-claritag-to-the-mena-region/ 2025-11-19T09:04:07Z https://www.hikma.com/news/inspiring-women-of-hikma-meet-susana-pereira-sr-director-quality-systems-validation-eu-mena-injectables/ 2025-11-24T12:29:47Z https://www.hikma.com/news/hikma-celebrates-20-years-on-the-london-stock-exchange/ 2025-11-21T13:25:02Z https://www.hikma.com/news/european-injectables-growth-a-qa-with-nassim-rahmani-associate-vp-commercial-europe-canada/ 2026-01-06T14:02:49Z https://www.hikma.com/news/hikma-launches-tyzavan-vancomycin-injection-usp-in-the-us/ 2025-12-08T16:12:11Z https://www.hikma.com/news/hikma-announces-ceo-change-and-board-appointment/ 2026-01-07T12:11:03Z https://www.hikma.com/news/inspiring-women-of-hikma-meet-cristina-cagnazzi-finance-director-hikma-italy/ 2026-01-15T10:16:37Z https://www.hikma.com/news/supporting-breast-cancer-awareness-month-at-hikma/ 2025-12-23T13:35:15Z https://www.hikma.com/news/exploring-partnership-opportunities-with-hikma-pharmaceuticals/ 2026-01-07T12:41:32Z https://www.hikma.com/news/hikma-achieves-b-scores-in-climate-change-and-water-security-in-2025-cdp-assessment/ 2026-01-15T07:05:49Z https://www.hikma.com/news/hikma-announces-launch-of-enoby-denosumab-qbde-and-xtrenbo-denosumab-qbde-referencing-prolia-and-xgeva-respectively/ 2026-01-19T12:04:53Z https://www.hikma.com/news/notice-of-results-9/ 2026-02-03T07:02:19Z https://www.hikma.com/news/hikma-rd-innovation-in-clinical-research-meet-hiba-kamal/ 2026-02-11T09:55:44Z https://www.hikma.com/news/inspired-at-hikma-meet-ana-santos-perez/ 2026-02-13T15:25:19Z https://www.hikma.com/news/hikma-launches-authorised-generic-of-nucynta-tapentadol-in-the-us/ 2026-02-25T12:00:13Z https://www.hikma.com/news/hikma-delivers-group-revenue-and-profit-growth-and-announces-share-buyback-and-leadership-changes/ 2026-02-26T07:01:41Z https://www.hikma.com/news/hikma-launches-authorised-generic-of-nucynta-er-tapentadol-extended-release-in-the-us/ 2026-03-11T13:03:02Z https://www.hikma.com/news/hikma-rd-innovation-in-formulation-development-meet-hamza-qassim/ 2026-03-17T09:24:25Z https://www.hikma.com/news/investing-in-rd-to-drive-high-value-pipeline-delivery/ 2026-03-18T09:00:59Z https://www.hikma.com/news/investing-in-manufacturing-excellence-at-hikma/ 2026-03-18T09:01:33Z https://www.hikma.com/news/investing-in-mena-to-expand-access-and-drive-growth/ 2026-03-18T09:01:40Z https://www.hikma.com/news/investing-in-strategic-partnerships-driving-growth-in-the-us-and-mena/ 2026-03-18T09:01:46Z https://www.hikma.com/news/investing-in-the-development-of-our-people-for-long-term-growth/ 2026-03-18T09:01:51Z https://www.hikma.com/sitemap/ 2024-03-19T14:48:59Z https://www.hikma.com/contact/ 2024-12-11T15:10:14Z https://www.hikma.com/contact/us-locations/ 2025-06-09T09:43:53Z https://www.hikma.com/contact/europe-locations/ 2026-03-19T09:54:22Z https://www.hikma.com/contact/mena-locations/ 2025-04-15T10:15:30Z https://www.hikma.com/contact/canada-locations/ 2025-11-12T10:12:21Z https://www.hikma.com/document-hub/ 2024-04-16T11:48:56Z https://www.hikma.com/useful-links/ 2024-03-19T14:50:23Z https://www.hikma.com/useful-links/report-a-possible-adverse-event/ 2024-12-16T11:29:44Z https://www.hikma.com/useful-links/terms-of-use/ 2026-02-25T12:36:08Z https://www.hikma.com/useful-links/disclaimer/ 2024-01-30T10:21:54Z https://www.hikma.com/useful-links/privacy-policy/ 2025-12-05T17:40:49Z https://www.hikma.com/useful-links/community-guidelines/ 2024-02-01T19:41:15Z https://www.hikma.com/useful-links/modern-slavery-act-statement/ 2025-05-20T09:50:12Z https://www.hikma.com/useful-links/subscribe-to-newsletter/ 2024-01-15T09:17:41Z https://www.hikma.com/useful-links/cookie-policy/ 2024-02-14T14:26:51Z https://www.hikma.com/locations/ 2024-03-19T14:50:26Z https://www.hikma.com/en-dz/ 2025-11-20T11:17:03Z https://www.youtube.com/watch?v=BHhiGFPWBNE Video Video https://www.youtube.com/watch?v=BHhiGFPWBNE https://www.hikma.com/en-ca/ 2024-09-19T11:31:03Z https://www.hikma.com/en-ca/overview/ 2026-03-31T09:07:09Z https://www.hikma.com/en-ca/products/ 2026-03-31T12:18:08Z https://www.hikma.com/en-eg/ 2025-11-20T11:06:34Z https://www.hikma.com/en-iq/ 2024-09-19T14:40:56Z https://www.hikma.com/en-jo/ 2025-11-10T12:06:02Z https://www.hikma.com/en-sa/ 2025-11-20T10:58:20Z https://www.hikma.com/en-ma/ 2025-11-10T12:29:01Z https://www.hikma.com/en-ma/overview/ 2025-11-10T12:30:43Z https://www.hikma.com/en-ma/products/ 2024-09-19T14:46:30Z https://www.hikma.com/pt-en/ 2025-07-07T14:27:57Z https://www.hikma.com/pt-en/overview/ 2025-07-07T14:38:40Z https://www.hikma.com/pt-en/products/ 2025-07-29T10:04:05Z https://www.hikma.com/pt-en/sustainability/ 2025-07-08T05:36:09Z https://www.hikma.com/en-tn/ 2025-11-10T12:22:49Z https://www.hikma.com/en-ae/ 2024-09-19T14:53:55Z https://www.hikma.com/en-us/ 2024-02-07T10:35:17Z https://www.youtube.com/watch?v=cct2q-Yp4K0 Video Video https://www.youtube.com/watch?v=cct2q-Yp4K0 https://www.hikma.com/en-us/overview/ 2025-12-17T06:56:01Z https://www.youtube.com/watch?v=dGNEXPNOUw4 Video Video https://www.youtube.com/watch?v=dGNEXPNOUw4 https://www.hikma.com/en-us/products/ 2026-01-09T14:59:32Z https://www.hikma.com/en-us/cmo-injectables/ 2025-09-25T09:53:11Z https://www.hikma.com/en-us/cmo/ 2025-05-15T11:22:38Z https://youtu.be/NQ5CjGJ0YJQ Video Video https://www.hikma.com/media/frbepnjo/hikma-503b-websitefinal-vid.mp4 Video Video https://youtu.be/NQ5CjGJ0YJQ https://www.hikma.com/media/frbepnjo/hikma-503b-websitefinal-vid.mp4 https://www.hikma.com/en-us/503b/ 2024-02-29T10:22:21Z https://www.hikma.com/en-uk/ 2024-05-30T10:03:37Z https://www.hikma.com/en-uk/responsibility/ 2024-05-31T13:23:33Z https://www.hikma.com/individual-rights-request-form/ 2025-01-03T16:41:38Z https://www.hikma.com/style-guide/ 2025-11-06T17:31:20Z https://www.youtube.com/watch?v=vYHrtfTOnpg Video Video https://www.youtube.com/watch?v=sVklq-yaEJw Video Video https://www.youtube.com/watch?v=vYHrtfTOnpg https://www.youtube.com/watch?v=sVklq-yaEJw https://www.hikma.com/media/c4tbquxq/hikma-ar24-nom.pdf https://www.hikma.com/media/gyvhfbbn/hikma-agm-2025-consent-letter-executed-by-citi-13-mar-2025.pdf https://www.hikma.com/media/wdmdav0t/hikma-agm-2025-rule-9-waiver-faqs.pdf https://www.hikma.com/media/wx4h3tw2/250424-final-results-of-agm.pdf https://www.hikma.com/media/bt5ngmh1/hikma-annual-report-2024.pdf https://www.hikma.com/media/xlohluxg/hikma_nom-2024.pdf https://www.hikma.com/media/dwvbd3ln/210423-plc-articles-of-association-2021-with-date.pdf https://www.hikma.com/media/iwzlk30l/16-citi-consent-letter-13-march-2024_redacted.pdf https://www.hikma.com/media/lwkkbpay/240425-final-results-of-agm.pdf https://www.hikma.com/media/jirfeccg/combined-2024-press-release-and-bfr-vfinal.pdf https://www.hikma.com/media/05enpftu/fy-2024-presentation-vfinal.pdf https://www.hikma.com/media/bzrhiht4/2024-preliminary-results-presentation-transcript.pdf https://www.hikma.com/media/dpkfemu5/hikma_fy24_results_transcript-260225.pdf https://www.hikma.com/html-summary/2025-interim-results-khalid-nabilsi-cfo/ 2026-01-15T09:51:17Z https://www.hikma.com/html-summary/2025-interim-results-riad-mishlawi-ceo/ 2026-01-13T12:01:58Z https://www.hikma.com/html-summary/riad-mishlawi-ceo-2024-full-year-results/ 2026-01-13T12:08:38Z https://www.hikma.com/html-summary/hikma-pharmaceuticals-plc-2025-full-year-results-combined-press-release-vfinal/ 2026-03-18T10:30:34Z